(97556.0, 'cells control viral infection') 
(95819.0, '2 0 1 1') 
(94562.0, 'cells following viral infection') 
(94176.0, '1 cells (~ 1') 
(91233.0, 'subsequent viral protein 1') 
(91000.0, 'virus protein 1') 
(90382.0, '1 upon virus infection') 
(89141.0, 'length virus protein 2') 
(87942.0, 'viral protein 1') 
(87942.0, '1 viral protein') 
(87895.0, 'influenza virus infected cells') 
(86711.0, 'cell motility protein 1') 
(86602.0, '1 1 2') 
(86532.0, 'tim 1 cell protein') 
(86289.0, 'virus infected cells compared') 
(85973.0, '1 virus infection') 
(85621.0, 'human influenza virus infection') 
(84726.0, 'putative viral protein 2') 
(84600.0, 'new human viral infection') 
(84537.0, '1 infection 1') 
(83953.0, 'virus including viral replication') 
(83684.0, '1 host cell proteins') 
(83541.0, 'viral nonstructural protein 2') 
(83486.0, '1 human mast cells') 
(83371.0, 'rna virus protein 7') 
(83196.0, '1 influenza virus c') 
(83071.0, 'viral protein 2') 
(83015.0, 'specific respiratory virus infection') 
(82825.0, 'human immunodeficiency virus 1') 
(82825.0, '1 human immunodeficiency virus') 
(82784.0, 'different cell virus systems') 
(82759.0, 'human parainfluenza virus 1') 
(82734.0, 'cells including endothelial cells') 
(82587.0, '1 human infection due') 
(82049.0, 'increased viral protein expression') 
(81995.0, 'cells without viral dna') 
(81989.0, 'virus infection progression 2') 
(81782.0, 'borna disease virus 1') 
(81704.0, 'including influenza virus infection') 
(81653.0, 'protein mediates viral infection') 
(81619.0, 'virus n protein expression') 
(81601.0, '1 could enter cells') 
(81395.0, '2 0 1 5') 
(81142.0, 'human immune cells could') 
(80986.0, 'virus specific cd8 1') 
(80922.0, 'treated virus control cells') 
(80736.0, 'h 2 cells rna') 
(80488.0, '1 cm 3 1') 
(80386.0, '1 cells post infected') 
(80365.0, 'cells expressing viral proteins') 
(80222.0, 'respiratory viral infection data') 
(80127.0, '1 patients received 1') 
(80083.0, 'host cell protein expression') 
(79985.0, 'dna binding protein 1') 
(79982.0, '2 infected cells compared') 
(79940.0, 'virus infected cells leading') 
(79921.0, 'one major viral protein') 
(79570.0, '1 virus immune serum') 
(79321.0, '1 cells 10 times') 
(79306.0, 'wt virus infected cells') 
(79202.0, 'infected cells exhibit virus') 
(78715.0, 'stranded virus infected cells') 
(78646.0, 'viral infection including influenza') 
(78561.0, 'viral n protein expression') 
(78534.0, 'viral genome positive cells') 
(78447.0, 'h 1 2 5') 
(78392.0, 'least one viral protein') 
(78386.0, 'vaccinia virus infected cells') 
(78173.0, '91 virus infected cells') 
(78161.0, 'infected cells amplify virus') 
(78140.0, 'parent virus infected cells') 
(78117.0, 'kill virus infected cells') 
(78063.0, 'binding protein type 1') 
(78048.0, 'human rna virus infections') 
(78044.0, '2 viral infection') 
(78029.0, 'influenza virus n protein') 
(77985.0, 'tc virus infected cells') 
(77980.0, 'viral e protein gene') 
(77847.0, 'δg virus infected cells') 
(77808.0, 'myxoma virus infected cells') 
(77801.0, 'lysing virus infected cells') 
(77774.0, 'virus infected cells') 
(77603.0, 'viral antigen positive cells') 
(77348.0, 'associated virus type 2') 
(77341.0, 'respiratory virus infection among') 
(77298.0, '2 cells without treatment') 
(77249.0, 'viral protein expression systems') 
(77152.0, '1 infected vero cells') 
(77131.0, 'study influenza virus infection') 
(76984.0, 'infected cells (< 1') 
(76970.0, 'terminal gene 1 protein') 
(76729.0, '1 binds viral rna') 
(76428.0, 'associated membrane protein 1') 
(76343.0, '1 high cells') 
(76338.0, '1 infected cells') 
(76338.0, '1 cells infected') 
(76247.0, 'specific protein 1') 
(76032.0, 'virus could prevent infection') 
(76007.0, '1 e 1 6') 
(75967.0, 'group 1 includes cells') 
(75889.0, 'human immunodeficiency virus infection') 
(75839.0, 'viral specific protein recognized') 
(75760.0, 'cells activate b cells') 
(75684.0, '1 days per 1') 
(75545.0, 'cells stimulate b cells') 
(75506.0, 'including activator protein 1') 
(75469.0, 'different viral infection models') 
(75443.0, '1 viral rna') 
(75384.0, 'decreased viral protein expression') 
(75347.0, 'including viral protein translation') 
(75286.0, '2 cases per 1') 
(75220.0, '1 viral proteins gp120') 
(75117.0, 'virus hijacks host cells') 
(75099.0, '1 expressing cells compared') 
(75028.0, 'cells release infectious virus') 
(74927.0, 'newcastle disease virus infection') 
(74890.0, 'viral protein data') 
(74796.0, '1 provided c 1') 
(74791.0, 'influenza virus fusion protein') 
(74772.0, 'influenza b virus infection') 
(74763.0, '1 viral proteins') 
(74716.0, 'viral infected cells') 
(74676.0, 'viral gene 1 polyprotein') 
(74673.0, 'two viral models could') 
(74650.0, 'h 1 n 1') 
(74625.0, 'specific viral protein') 
(74546.0, 'binding protein site 1') 
(74545.0, '2 0 1 0') 
(74500.0, '2 0 1 6') 
(74427.0, 'two influenza virus infections') 
(74402.0, '5 influenza virus patients') 
(74350.0, 'virus infection following treatment') 
(74240.0, '1 ÷ cells increased') 
(74118.0, 'influenza virus infection compared') 
(74095.0, 'virus infection could trigger') 
(74078.0, 'h 1 2 4') 
(74055.0, 'iba1 1 cells associated') 
(73983.0, 'hiv 1 target cells') 
(73966.0, 'h 1 cells across') 
(73912.0, 'c 1 cells') 
(73812.0, 'cells expressing virus antigen') 
(73764.0, 'viral protein production levels') 
(73749.0, '1 protein gene') 
(73671.0, 'type b virus infection') 
(73669.0, 'type antiviral protein 1') 
(73630.0, '2 virus rna') 
(73545.0, 'type virus infection induced') 
(73532.0, 'two virus dna sequences') 
(73529.0, 'type 2 viral infections') 
(73517.0, 'infected cells )), cell') 
(73433.0, '1 positive cells') 
(73398.0, 'cells following 1 ng') 
(73377.0, 'one viral protein') 
(73360.0, '1 dna virus') 
(73357.0, 'including viral gene expression') 
(73350.0, '1 reference virus strain') 
(73262.0, 'virus infection could') 
(73256.0, 'group 1 corona virus') 
(73216.0, 'two different cell systems') 
(73216.0, 'cell gene expression data') 
(73142.0, 'viral rna levels could') 
(73104.0, 'two additional viral proteins') 
(73059.0, '1 respiratory syncytial virus') 
(73016.0, 'influenza virus infection reported') 
(73010.0, 'viral infection could affect') 
(72964.0, 'viral protein whose expression') 
(72937.0, 'cells containing virus') 
(72891.0, 'persistent rna virus infection') 
(72819.0, 'human ebola virus disease') 
(72784.0, '1 protein expression') 
(72777.0, '1 respiratory virus') 
(72774.0, 'initial viral rna infection') 
(72735.0, 'dengue virus type 1') 
(72723.0, 'human influenza c virus') 
(72705.0, 'one dengue virus infection') 
(72689.0, 'cell following viral replication') 
(72681.0, 'influenza virus ha protein') 
(72679.0, 'influenza virus infection either') 
(72656.0, 'specific virus infection') 
(72600.0, '1 lung epithelial cells') 
(72599.0, 'viral enter host cells') 
(72595.0, 'analyzed viral protein expression') 
(72539.0, '1 influenza virus') 
(72474.0, 'two different virus preparations') 
(72441.0, 'viral protein expression plasmids') 
(72431.0, '1 â10 6 cells') 
(72424.0, '1 cell line showed') 
(72424.0, '1 b cells') 
(72414.0, 'viral immune cells infiltrating') 
(72293.0, '1 infection 3') 
(72281.0, '2 infected vero cells') 
(72275.0, 'viral np protein expression') 
(72253.0, 'viral protein based') 
(72233.0, 'kd cells virus replication') 
(72228.0, '1 virus results') 
(72203.0, 'without respiratory viral infection') 
(72173.0, 'infected cells throughout infection') 
(72128.0, 'buffer 1 containing 1') 
(72113.0, '1 red blood cells') 
(72034.0, 'type 1 herpes virus') 
(72006.0, 'severe influenza virus infection') 
(71957.0, 'viral protein synthesis 4') 
(71877.0, 'human immune cells compared') 
(71863.0, 'new viral disease among') 
(71863.0, 'infected cell protein synthesis') 
(71863.0, '7 1 number 1') 
(71846.0, 'infection control infection control') 
(71842.0, 'viral infection disease deserves') 
(71837.0, 'human primary cells infected') 
(71770.0, '1 cells compared') 
(71761.0, 'parainfluenza virus type 1') 
(71747.0, 'acute respiratory virus infection') 
(71743.0, '1 b cell culture') 
(71729.0, 'examine viral protein expression') 
(71705.0, 'stresses including virus infection') 
(71701.0, '2 0 1 8') 
(71674.0, 'polio virus type 1') 
(71643.0, '2 monolayer cells infected') 
(71599.0, 'potential viral target protein') 
(71597.0, '1 h 2 0') 
(71594.0, 'viral vp1 protein expression') 
(71589.0, 'cell wall protein gene') 
(71587.0, '1 b virus') 
(71583.0, 'including virus infection') 
(71575.0, 'primary influenza virus infection') 
(71565.0, 'rna virus infection') 
(71557.0, 'associated membrane protein 2') 
(71543.0, 'associated protein kinase 1') 
(71509.0, 'acute influenza virus infection') 
(71502.0, 'lymphotropic virus type 1') 
(71499.0, 'viral e6 protein expression') 
(71467.0, '2 infected cells') 
(71467.0, '2 cells infected') 
(71444.0, 'lymphotrophic virus type 1') 
(71362.0, 'influenza virus m2 protein') 
(71347.0, 'viral ie protein expression') 
(71298.0, 'respiratory viral infection compared') 
(71268.0, 'influenza virus infection models') 
(71198.0, 'influenza virus ns1 protein') 
(71162.0, 'viral protein expression') 
(71146.0, 'increased viral protein synthesis') 
(71128.0, 'host cells upon infection') 
(71086.0, 'human influenza virus type') 
(71057.0, 'cell immunolabeled cells increased') 
(71038.0, 'human influenza virus strains') 
(71029.0, '3 human cells') 
(71011.0, 'virus induced cell death') 
(71011.0, 'detect viral protein levels') 
(71003.0, 'like virus potato virus') 
(70997.0, 'influenza virus hemagglutinin protein') 
(70967.0, 'viral host protein interaction') 
(70964.0, '1 cell infected') 
(70867.0, '1 across epithelial cells') 
(70844.0, 'virus encounters target cells') 
(70841.0, 'induced following viral infection') 
(70813.0, '2 days per 1') 
(70754.0, 'cells expressing viral antigen') 
(70732.0, 'binding kinase 1 protein') 
(70700.0, '1 cell per well') 
(70683.0, 'viral antigen per cell') 
(70683.0, 'first human virus species') 
(70632.0, '1 virus strain kos') 
(70610.0, '1 virus strain mckrae') 
(70603.0, '1 virus strain') 
(70585.0, 'viral 2 =, 5') 
(70573.0, 'different host cell proteins') 
(70572.0, '2 viral rna') 
(70554.0, '1 particles per cell') 
(70547.0, '1 − p 1') 
(70533.0, 'five increased virus infection') 
(70532.0, 'virus protein interaction information') 
(70515.0, 'human parainfluenza virus 3') 
(70515.0, 'human parainfluenza 3 virus') 
(70456.0, 'virus protein interaction research') 
(70440.0, 'cell virus transmission rates') 
(70435.0, 'influenza virus gene expression') 
(70381.0, 'viral replication versus virus') 
(70369.0, 'envelope protein 2 gene') 
(70350.0, 'viral infection could exacerbate') 
(70333.0, 'small viral membrane protein') 
(70329.0, 'two different cell types') 
(70325.0, 'viral rna binding proteins') 
(70319.0, '1 ligand binding protein') 
(70276.0, 'viral infection could potentiate') 
(70221.0, '2 virus detection rate') 
(70217.0, '2 0 1 9') 
(70202.0, '1 3 10 6') 
(70200.0, 'infected cell protein 34') 
(70199.0, '1 0 1') 
(70199.0, '0 1 1') 
(70108.0, '1 inhibitor treated cells') 
(69962.0, '2 cells showed perk') 
(69959.0, 'including h5n1 viral infection') 
(69958.0, 'rich binding protein 1') 
(69952.0, 'two different cell lines') 
(69926.0, '2 cells might show') 
(69865.0, 'several human viral infections') 
(69858.0, 'nak associated protein 1') 
(69854.0, 'associated protein 1') 
(69835.0, 'influenza virus among patients') 
(69779.0, '1 n h 2') 
(69738.0, '1 env negative cells') 
(69725.0, '1 case per 2') 
(69717.0, '2 4 2 7') 
(69674.0, 'highmobility group protein 1') 
(69674.0, '2 0 2 0') 
(69670.0, '1 protein group') 
(69656.0, 'viral host cell range') 
(69624.0, 'control viral gene expression') 
(69614.0, '1 per 1') 
(69598.0, 'specific viral infection') 
(69584.0, '2 6 2 6') 
(69572.0, 'treat human viral disease') 
(69549.0, 'least 1 − 1') 
(69546.0, '2 3 2 tablet') 
(69524.0, 'h 1 cells') 
(69524.0, 'cells 1 h') 
(69506.0, '1 virus replication inhibitions') 
(69492.0, 'influenza virus infection remains') 
(69483.0, '1 protein levels') 
(69474.0, '1 virus replication') 
(69471.0, 'like virus 1') 
(69471.0, '1 like virus') 
(69380.0, 'major viral surface protein') 
(69320.0, 'infected cell protein null') 
(69295.0, 'binding protein 5 gene') 
(69285.0, 'disease including virus isolation') 
(69280.0, '1 c8166 target cells') 
(69268.0, 'p 1 cells') 
(69266.0, 'human respiratory viral infections') 
(69265.0, '1 target cells') 
(69245.0, '2 4 virus') 
(69204.0, 'induced transmembrane protein 1') 
(69180.0, 'host cell protein synthesis') 
(69177.0, 'primary viral infection associated') 
(69157.0, 'systemic type 1 cell') 
(69149.0, 'viral protein 4') 
(69149.0, '1 proteins could provide') 
(69113.0, 'human primary respiratory cells') 
(69102.0, 'infected cells could provide') 
(69092.0, 'common respiratory viral infection') 
(69091.0, 'demonstrate viral protein levels') 
(69087.0, 'two different rna viruses') 
(69047.0, 'tax1 binding protein 1') 
(69047.0, 'several viral infection models') 
(69043.0, 'binding protein 1') 
(69037.0, 'infected cells showed 4') 
(69023.0, 'cells directly kill virus') 
(69009.0, 'including protein expression analysis') 
(69002.0, 'including human ips cells') 
(68992.0, 'experimental influenza virus infection') 
(68983.0, 'confirmed respiratory virus infection') 
(68968.0, 'intestinal epithelial cells 1') 
(68956.0, 'cells 2 h prior') 
(68927.0, 'human rna virus biology') 
(68903.0, '2 â 10 1') 
(68902.0, 'including ebola virus disease') 
(68883.0, '1 viral genome sequencing') 
(68877.0, 'infection among approximately 1') 
(68858.0, 'cell leukemia virus type') 
(68851.0, 'cases virus species could') 
(68839.0, 'induced maturation protein 1') 
(68788.0, 'influenza c virus rna') 
(68784.0, '2 host cells') 
(68745.0, 'n protein cells') 
(68745.0, 'confirmed influenza virus infection') 
(68738.0, 'activity upon viral infection') 
(68734.0, '2 mb dna virus') 
(68726.0, 'pathologies including viral infection') 
(68721.0, '1 reduced virus infectivity') 
(68701.0, '5 virus strains used') 
(68689.0, 'acute respiratory viral infection') 
(68687.0, 'cell culture derived virus') 
(68679.0, 'type 2 alveolar cells') 
(68679.0, 'alveolar type 2 cells') 
(68668.0, 'viral infection including enteroviruses') 
(68651.0, 'associated circular virus 2') 
(68638.0, '2 positive h9 cells') 
(68631.0, 'first viral protein synthesized') 
(68574.0, 'human infection disease models') 
(68525.0, 'including viral infection') 
(68481.0, 'specific b cells following') 
(68451.0, 'acute influenza viral infection') 
(68451.0, '10 2 10 3') 
(68450.0, 'high viral rna levels') 
(68435.0, 'including human immunodeficiency virus') 
(68427.0, 'clone 1 cells treated') 
(68401.0, 'cell lymphotropic virus type') 
(68400.0, 'g 1 synchronized cells') 
(68400.0, 'different influenza virus strains') 
(68394.0, 'viral lower respiratory infection') 
(68389.0, 'respiratory rna virus infections') 
(68373.0, 'prevent influenza virus infection') 
(68366.0, 'h 1 cell activation') 
(68348.0, 'first human virus identified') 
(68328.0, 'associated virus 2') 
(68302.0, 'viral supernatant containing 1') 
(68290.0, 'least 1 viral pathogen') 
(68269.0, '1 protein vpu induced') 
(68226.0, 'cells 1 hour prior') 
(68204.0, 'inhibit influenza virus infection') 
(68187.0, 'active viral infection among') 
(68175.0, 'protein blocks virus replication') 
(68169.0, 'including influenza virus infections') 
(68166.0, 'c 2 h 2') 
(68143.0, 'type 1 e4 protein') 
(68141.0, 'major viral structural protein') 
(68137.0, 'treated human cells showed') 
(68130.0, 'including human papilloma virus') 
(68129.0, 'cells following rsv infection') 
(68126.0, 'protein levels increased 3') 
(68126.0, '3 protein levels increased') 
(68120.0, 'induced apolipo protein 1') 
(68109.0, 'including viral rna replication') 
(68104.0, 'dc cells viral peptide') 
(68069.0, '1 annotation per protein') 
(68043.0, 'two viral capsid proteins') 
(68028.0, 'human rna virus') 
(68028.0, '10 2 viral copies') 
(68026.0, '1 n protein cd4') 
(68019.0, '1 day following infection') 
(68003.0, 'viral vp4 protein levels') 
(67988.0, 'different human cell types') 
(67969.0, 'human influenza virus production') 
(67962.0, 'dna virus infection depends') 
(67931.0, 'cell membrane surface protein') 
(67913.0, '2 protein expression') 
(67890.0, '2 infection could protect') 
(67886.0, '1 novel corona virus') 
(67879.0, 'type 2 myeloid cells') 
(67864.0, 'dengue virus type 2') 
(67861.0, 'viral protein levels') 
(67858.0, 'human disease cell tumors') 
(67850.0, 'control virus infection') 
(67839.0, '1 infected patients might') 
(67835.0, 'hepatitis c virus infection') 
(67827.0, 'new viral type could') 
(67815.0, 'virus infection studies') 
(67811.0, 'cells showed infection') 
(67779.0, 'new human virus resulting') 
(67758.0, 'respiratory tract virus infection') 
(67729.0, 'virus cause human infections') 
(67686.0, '2 associated x protein') 
(67666.0, 'viral gene expression levels') 
(67659.0, 'dengue virus e protein') 
(67658.0, 'human health 1') 
(67656.0, 'dendritic cells murine cells') 
(67651.0, '2 virus type mrnas') 
(67650.0, 'viral infection often results') 
(67640.0, 'new virus infection') 
(67629.0, 'viral protein positive') 
(67556.0, 'p3hr 1 cells revealed') 
(67534.0, 'least 3 viral proteins') 
(67473.0, 'including newcastle disease virus') 
(67472.0, 'viruses infect human cells') 
(67465.0, 'influenza virus infection leads') 
(67465.0, 'influenza virus analysis based') 
(67456.0, 'target specific viral proteins') 
(67455.0, 'newcastle disease virus rna') 
(67438.0, '1 point per 2') 
(67437.0, 'rabies virus p protein') 
(67437.0, '1 b cell subset') 
(67433.0, 'least 1 virus') 
(67430.0, '1 virus present') 
(67429.0, 'cells (> 500 cells') 
(67428.0, 'avian viral protein sequences') 
(67404.0, 'type 2 cells') 
(67404.0, 'e protein reduces virus') 
(67404.0, '2 type cells') 
(67403.0, '3 1 10 8') 
(67373.0, 'cell free virus obtained') 
(67323.0, 'helper cell type 1') 
(67323.0, 'containing maguk protein 1') 
(67319.0, 'containing protein 1') 
(67305.0, '1 infection induced activation') 
(67300.0, 'influenza b virus rna') 
(67288.0, 'cell subset type 1') 
(67276.0, 'avian influenza virus infection') 
(67260.0, 'described viral respiratory infection') 
(67255.0, 'influenza virus infection plays') 
(67227.0, 'several different viral infections') 
(67226.0, 'viral infection based') 
(67223.0, 'cells contain virus') 
(67223.0, 'cell derived factor 1') 
(67206.0, 'residual host cell protein') 
(67181.0, 'influenza virus infection inhibits') 
(67177.0, 'host cell adhesion protein') 
(67175.0, 'influenza virus h1n1 infection') 
(67175.0, 'h1n1 influenza virus infection') 
(67173.0, 'virus infects skin cells') 
(67154.0, '1 ml virus') 
(67153.0, '1 +/− 1 days') 
(67145.0, 'bovine virus diarrhea virus') 
(67143.0, 'one influenza b virus') 
(67122.0, 'though influenza virus infection') 
(67119.0, 'cells expressing core protein') 
(67118.0, '1 cells treated') 
(67112.0, 'respiratory virus infection act') 
(67095.0, '1 cells specifically inhibits') 
(67091.0, 'especially following virus infection') 
(67086.0, 'prior respiratory viral infection') 
(67084.0, 'like type 3 cells') 
(67062.0, 'related protein 1') 
(67062.0, '2 − 1 n') 
(67062.0, '2 n − 1') 
(67060.0, '4 viral rna levels') 
(67037.0, 'h5n1 influenza virus infection') 
(67029.0, '1 major capsid protein') 
(67028.0, 'viral respiratory infections could') 
(67010.0, 'study virus infection') 
(66998.0, '1 increased 2') 
(66995.0, 'p 1 1') 
(66971.0, 'swine influenza virus infection') 
(66970.0, 'one cell infection equals') 
(66952.0, 'treat influenza virus infection') 
(66932.0, 'established following virus infection') 
(66926.0, 'seasonal influenza virus infection') 
(66907.0, '2 cells due') 
(66892.0, 'cells following mhv infection') 
(66890.0, 'parainfluenza type 2 virus') 
(66885.0, 'deficient cells following infection') 
(66878.0, 'zika virus e protein') 
(66878.0, 'virus except h1n1 virus') 
(66878.0, 'cell responses eliminate virus') 
(66865.0, '2 strain enters cells') 
(66857.0, 'level viral protein synthesis') 
(66844.0, 'virus except ebola virus') 
(66835.0, '1 e 1') 
(66831.0, 'specific viral surface proteins') 
(66829.0, 'lower viral protein concentrations') 
(66827.0, 'viral rna binding activity') 
(66827.0, 'symptomatic respiratory virus infection') 
(66787.0, 'model zika virus infection') 
(66785.0, 'respiratory virus infection episodes') 
(66742.0, 'wild type virus infection') 
(66732.0, 'help control viral infection') 
(66726.0, 'h 2 0 2') 
(66710.0, 'samples containing one virus') 
(66709.0, 'virus induced severe disease') 
(66702.0, 'lethal influenza virus infection') 
(66682.0, 'controlling respiratory virus infection') 
(66672.0, 'cells towards virus') 
(66672.0, '1 cells expressing tac') 
(66631.0, 'two viral proteins') 
(66630.0, 'virus enters susceptible cells') 
(66628.0, 'different viral respiratory infections') 
(66623.0, 'viral protein 6') 
(66614.0, 'cd11c 1 cells isolated') 
(66597.0, 'simian virus 40 virus') 
(66584.0, '1 expressing cells') 
(66584.0, '1 cells expressing') 
(66575.0, 'least 1 viral agent') 
(66533.0, 'viral cell culture methods') 
(66533.0, 'cells termed th17 cells') 
(66525.0, 'ebola virus enters cells') 
(66516.0, '1 interacting human proteins') 
(66514.0, 'antigen positive cells could') 
(66513.0, '1 per cell') 
(66507.0, '1 n protein preimmune') 
(66485.0, '1 1 site') 
(66484.0, 'r 1 ¼ 1') 
(66480.0, 'hamper virus protein production') 
(66472.0, '1 n protein') 
(66462.0, 'sf9 host cell protein') 
(66459.0, '1 virus particles') 
(66458.0, '1 ml à 1') 
(66452.0, 'infected human dendritic cells') 
(66443.0, '1 x 105 cells') 
(66439.0, 'major viral core protein') 
(66424.0, 'dna virus infection') 
(66416.0, 'host cell protein impurities') 
(66416.0, 'apoptosis following virus infection') 
(66416.0, '1 viral replication') 
(66399.0, 'virus initially encounters cells') 
(66392.0, '1 x 106 cells') 
(66390.0, '1 cells resulted') 
(66389.0, '1 %), parainfluenzae virus') 
(66385.0, 'non structural protein 1') 
(66383.0, '1 x 104 cells') 
(66375.0, 'common respiratory virus could') 
(66374.0, 'virus following successful infection') 
(66372.0, 'host cell protein') 
(66369.0, 'virus early gene expression') 
(66369.0, 'early virus gene expression') 
(66362.0, 'virus e protein') 
(66347.0, 'hepatitis b virus infection') 
(66335.0, 'n pro viral protein') 
(66334.0, 'influenza virus infection 54') 
(66332.0, 'including human cell lines') 
(66322.0, '1 respiratory tract infection') 
(66311.0, 'human respiratory epithelial cells') 
(66290.0, 'latent membrane protein 1') 
(66266.0, 'human cells persistently infected') 
(66262.0, 'virus producing cells') 
(66257.0, 'viral protein genes') 
(66233.0, 'major viral regulatory protein') 
(66218.0, 'influenza virus infection activates') 
(66216.0, '2 cord blood cells') 
(66214.0, 'herpes virus types 1') 
(66199.0, 'investigate influenza virus infection') 
(66196.0, 'mannosidase like protein 1') 
(66177.0, 'host cell gene expression') 
(66171.0, '1 sirna transfected cells') 
(66156.0, 'influenza virus infection correlates') 
(66135.0, '1 hcv permissive cells') 
(66132.0, 'bovine virus diarrhoea virus') 
(66126.0, 'like protein 1') 
(66126.0, '1 like protein') 
(66123.0, 'respiratory syncytial virus infection') 
(66097.0, 'virus infection analysis') 
(66086.0, '1 1 9 tion') 
(66083.0, '1 viral genome') 
(66056.0, '5 infected cells occurs') 
(66051.0, 'intranasal influenza virus infection') 
(66044.0, 'a549 cells without infection') 
(66043.0, 'early 1 protein promotes') 
(66041.0, '1 mm isopropyl 1') 
(66024.0, '1 million cells') 
(66010.0, '1 cell toxicity assay') 
(65997.0, 'influenza virus specific antibodies') 
(65996.0, 'influenza h3n2 virus infection') 
(65996.0, 'h3n2 influenza virus infection') 
(65995.0, '1 x lo6 cells') 
(65985.0, '1 mrna expression data') 
(65977.0, 'productively infected human cells') 
(65977.0, 'human cells productively infected') 
(65964.0, 'infected human rpe cells') 
(65943.0, 'novel protein − protein') 
(65941.0, 'parainfluenza virus types 1') 
(65935.0, 'influenza virus infection highlights') 
(65934.0, '1 viral membrane') 
(65932.0, 'infected human diploid cells') 
(65925.0, 'confirmed viral respiratory infection') 
(65924.0, '17 cl 1 cells') 
(65918.0, 'initiating influenza virus infection') 
(65906.0, 'new virus particles could') 
(65895.0, 'two cases viral concentration') 
(65894.0, 'virus protein surface') 
(65890.0, 'ifn following viral infection') 
(65888.0, 'virus clearance following infection') 
(65882.0, 'could detect viral rna') 
(65881.0, 'quadruple respiratory virus infection') 
(65865.0, 'infected human cells') 
(65865.0, 'human cells infected') 
(65844.0, '17 c1 1 cells') 
(65841.0, 'respiratory virus infection') 
(65826.0, 'vaccine virus infection') 
(65819.0, 'binding protein type 3') 
(65815.0, '1 tumor cells') 
(65809.0, '1 murine macrophage cells') 
(65808.0, 'different respiratory virus groups') 
(65805.0, '1 bat cells') 
(65800.0, 'acquiring influenza virus infection') 
(65798.0, 'different viral structural proteins') 
(65793.0, 'virus containing 2') 
(65775.0, '1 viral capsid domain') 
(65771.0, 'viral gene expression compared') 
(65762.0, 'commonly associated viral infection') 
(65733.0, '1 − 2 days') 
(65727.0, 'rs virus g protein') 
(65718.0, '1 ml 1') 
(65703.0, 'two immune cells') 
(65684.0, 'influenza virus infection looked') 
(65682.0, 'lymphotropic virus types 1') 
(65661.0, 'influenza virus infection frontiers') 
(65660.0, '1 residues 1') 
(65659.0, 'bovine virus diarrea virus') 
(65652.0, 'called virus passage 1') 
(65641.0, '1 mutant virus') 
(65638.0, 'specific b cell activity') 
(65637.0, 'resisting influenza virus infection') 
(65633.0, 'one virus could') 
(65632.0, 'communityacquired influenza virus infection') 
(65604.0, 'coatomer protein complex 1') 
(65603.0, 'influenza virus infection') 
(65593.0, '1 marker every 1') 
(65592.0, 'specific viral structural proteins') 
(65582.0, 'virus g protein') 
(65582.0, 'compartments following virus infection') 
(65566.0, '1 linking regions 1') 
(65558.0, 'different cell surface proteins') 
(65557.0, 'receptor interacting protein 1') 
(65531.0, 'three viral rna species') 
(65503.0, 'ebola virus vp40 virus') 
(65492.0, 'mediated viral infection due') 
(65489.0, 'critical g 1 cell') 
(65482.0, 'viral infection requires binding') 
(65480.0, '1 receptor accessory protein') 
(65471.0, '1 %); type 2') 
(65464.0, 'expressed following viral infection') 
(65448.0, '1 þ murine cells') 
(65417.0, 'human immunodeficiency virus infected') 
(65407.0, 'major viral capsid protein') 
(65401.0, 'stained undamaged virus cells') 
(65401.0, 'measles virus fusion protein') 
(65391.0, 'virus infecting cells') 
(65372.0, 'following zika virus infection') 
(65365.0, '1 viral structure') 
(65357.0, 'plant viral rna 3') 
(65356.0, 'protein vaccines onto 1') 
(65343.0, 'cells þ virus') 
(65342.0, 'protein 1 h') 
(65342.0, 'different influenza viral strains') 
(65327.0, 'virus gag structural protein') 
(65292.0, 'virus infection results') 
(65290.0, 'eae without virus infection') 
(65283.0, '2 6 1') 
(65266.0, 'viral n 92 protein') 
(65266.0, 'human influenza virus types') 
(65241.0, 'h 1 cell differentiation') 
(65193.0, 'respiratory viral infection appears') 
(65186.0, 'specific viral proteins involved') 
(65184.0, 'virus specific rna') 
(65147.0, 'cells expressing viral nucleoprotein') 
(65130.0, 'exposed cd11c 1 cells') 
(65125.0, '1 per cent 2') 
(65124.0, '1 %), piv 1') 
(65111.0, '1 cells took place') 
(65069.0, 'virus adsorption cells') 
(65055.0, '1 viral load assays') 
(65048.0, 'virus propagation l132 cells') 
(65045.0, 'human influenza virus isolates') 
(65040.0, '1 virus contains gpi') 
(65034.0, 'virus inoculum cells') 
(65034.0, 'cells kill virus') 
(65027.0, 'one specific virus') 
(64996.0, 'either viral protein 1a') 
(64995.0, '10 protein expression levels') 
(64990.0, 'direct sars virus infection') 
(64987.0, 'virus enters cells') 
(64986.0, 'cov viral protein epitopes') 
(64985.0, 'plasma cell protein production') 
(64983.0, 'associated protein 2') 
(64983.0, 'associated 2 protein') 
(64976.0, '1 protein production') 
(64971.0, '1 challenge virus') 
(64967.0, 'severe respiratory viral disease') 
(64947.0, '0 1 6 5') 
(64940.0, 'two control cell lines') 
(64939.0, '1 cells express fgl2') 
(64935.0, '1 %), 1') 
(64933.0, 'virus causes respiratory disease') 
(64921.0, 'human pandemic influenza virus') 
(64906.0, 'hiv virus infection included') 
(64899.0, 'h 1 cell recruitment') 
(64899.0, 'antigen specific b cells') 
(64898.0, 'infected cells could act') 
(64887.0, 'viral surface protein ha') 
(64887.0, 'viral ha surface protein') 
(64873.0, '1 cells 35') 
(64856.0, 'virus following infection') 
(64856.0, 'following virus infection') 
(64854.0, 'viral lysatederived n protein') 
(64854.0, 'influenza virus rna genome') 
(64850.0, 'viral n protein') 
(64839.0, 'virus producer cells') 
(64833.0, 'virus penetrating cells') 
(64828.0, 'mouse hepatitis virus 2') 
(64826.0, '1 producing cells') 
(64823.0, '3 9 5 2') 
(64821.0, 'including various virus infections') 
(64817.0, '1 cells express mcar1') 
(64815.0, 'sendai virus h4infected cells') 
(64815.0, 'bovine herpes virus 1') 
(64812.0, 'including two different strains') 
(64803.0, 'various rna virus infections') 
(64792.0, 'viral infection control') 
(64792.0, 'control viral infection') 
(64790.0, 'sendai virus fusion protein') 
(64783.0, 'coxsackievirus b virus infection') 
(64780.0, '2 protein family 7') 
(64777.0, 'hepatitis c viral infection') 
(64762.0, 'infected host cells compared') 
(64761.0, 'infected cells without treatment') 
(64757.0, 'viral infection studies') 
(64755.0, 'two group 1 coronaviruses') 
(64754.0, 'virus invades cells') 
(64748.0, '1 cells suggesting') 
(64746.0, 'dsdna virus vaccinia virus') 
(64732.0, 'animals upon virus infection') 
(64731.0, '≥ 2 viral strains') 
(64724.0, 'macrophage inflammatory protein 1') 
(64717.0, 'based viral sequence analysis') 
(64702.0, 'virus cell surface') 
(64701.0, 'virus 907 cells') 
(64700.0, 'viral respiratory tract infection') 
(64698.0, '2 infection induces expression') 
(64691.0, 'virus cells') 
(64672.0, 'cell cell response') 
(64670.0, 'virus fusion protein') 
(64655.0, 'virus structural protein') 
(64653.0, 'h 2 cells') 
(64651.0, 'b virus infection') 
(64649.0, 'cd8 1 cells') 
(64640.0, 'recently developed viral protein') 
(64629.0, 'two parainfluenza virus infections') 
(64612.0, '2 protein levels') 
(64608.0, 'cpg binding protein 2') 
(64570.0, 'prepare virus stocks virus') 
(64563.0, 'human host cell factors') 
(64557.0, 'biosafety level 2 virus') 
(64545.0, 'viral surface protein exposed') 
(64534.0, '1 − 1') 
(64533.0, '1 vs 2 p') 
(64528.0, '1 cells displayed') 
(64525.0, '1 chicken cells') 
(64502.0, 'type virus infection') 
(64498.0, 'dengue virus serotype 1') 
(64481.0, '1 microvascular endothelial cells') 
(64473.0, 'hcw required 1 1') 
(64471.0, 'merozoite surface protein 1') 
(64470.0, 'acute viral respiratory disease') 
(64465.0, 'cell surface 2 days') 
(64456.0, '1 infection levels') 
(64454.0, '2 days cells') 
(64449.0, '1 infection via inhibition') 
(64448.0, 'feline herpes virus 1') 
(64446.0, 'cos 1 cells transfected') 
(64431.0, 'cells among human cd45') 
(64418.0, 'including parainfluenza virus 5') 
(64404.0, 'assembled viral membrane protein') 
(64394.0, '2 target cells') 
(64371.0, 'ensure viral protein production') 
(64369.0, 'three virus strains showed') 
(64363.0, '1 h post infection') 
(64362.0, 'human papilloma virus studies') 
(64361.0, 'dependent protein kinase 1') 
(64355.0, '1 cells transfected') 
(64354.0, 'used protein level data') 
(64354.0, 'intact cells 1') 
(64346.0, 'virus infected disease') 
(64330.0, 'mixed respiratory viral infection') 
(64316.0, '10 5 cells isolated') 
(64310.0, 'type 2 transmembrane protein') 
(64303.0, 'bovine papilloma virus 1') 
(64298.0, 'human hepatitis c virus') 
(64268.0, '1 part virus suspension') 
(64240.0, 'viral upper respiratory infection') 
(64240.0, 'several specific viral diseases') 
(64239.0, 'human herpes virus 4') 
(64238.0, 'predominant viral protein target') 
(64230.0, 'viral protein 7') 
(64203.0, 'virus infection via dc') 
(64203.0, 'positive cells could still') 
(64187.0, 'cell cells development') 
(64185.0, '09 virus infection compared') 
(64177.0, 'cells enhance viral clearance') 
(64174.0, 'viral protein genome') 
(64172.0, 'binding protein 2') 
(64151.0, 'several host cell proteins') 
(64151.0, 'influenza virus infected type') 
(64142.0, '1 patients including adults') 
(64142.0, '1 inhibited cell growth') 
(64137.0, '3 2b4 cells infected') 
(64132.0, 'treat viral respiratory infection') 
(64132.0, 'different target cells might') 
(64132.0, 'different cell populations including') 
(64117.0, 'h1n1 influenza viral infection') 
(64113.0, 'human protein whose expression') 
(64109.0, '1 infected human fibroblasts') 
(64103.0, 'new human virus') 
(64100.0, 'viral membrane protein exposes') 
(64097.0, 'human parainfluenza viruses 1') 
(64094.0, 'infected cells 3') 
(64094.0, '3 infected cells') 
(64094.0, '3 cells infected') 
(64091.0, 'viral membrane protein gh') 
(64087.0, 'bovine viral diarrhea virus') 
(64086.0, 'viral protein peptide segments') 
(64086.0, 'recombinant protein 1') 
(64078.0, 'viral large protein') 
(64072.0, 'preventing viral respiratory infection') 
(64072.0, 'preventing respiratory viral infection') 
(64071.0, 'different cell types including') 
(64064.0, 'helper subset 1 cells') 
(64059.0, '2 protein coding sequences') 
(64050.0, 'virus successfully killed 1') 
(64034.0, 'viral membrane protein 6k2') 
(64033.0, 'viral specific rna polymerase') 
(64032.0, '2 â 10 2') 
(64031.0, 'cell free virus stock') 
(64025.0, 'viral membrane protein') 
(64014.0, 'new viral strain based') 
(64010.0, 'virus cell culture') 
(64008.0, 'major viral protein shapiro') 
(63998.0, 'plasma cell producing virus') 
(63998.0, '1 virus variant') 
(63988.0, 'first human virus shown') 
(63984.0, 'specific host cell type') 
(63979.0, 'influenza h5n1 viral infection') 
(63978.0, 'infected cells could die') 
(63974.0, 'associated host cell proteins') 
(63973.0, 'viral protein function limits') 
(63952.0, 'viral infection study') 
(63946.0, '1 myocardial cells subjected') 
(63931.0, 'cellular protein protein') 
(63924.0, 'results toward viral infection') 
(63924.0, 'additional viral protein') 
(63920.0, 'activation decreased virus infection') 
(63919.0, 'infected cells could survive') 
(63911.0, '1 attenuated virus') 
(63910.0, 'viral infection via mechanisms') 
(63907.0, 'target cells inhibits infection') 
(63905.0, 'rna vaccine virus detection') 
(63890.0, 'virus ness ziona virus') 
(63881.0, 'targets specific viral proteins') 
(63880.0, 'infected parenchymal cells could') 
(63879.0, 'cell transcription factor protein') 
(63877.0, '1 naïve feeder cells') 
(63870.0, '1 protein reference database') 
(63859.0, 'secondary infection virus whereas') 
(63837.0, 'human myeloid immune cells') 
(63830.0, '3 cells per well') 
(63787.0, 'viral protein conformational changes') 
(63781.0, 'disrupt viral protein function') 
(63774.0, 'viral infection rate obtained') 
(63765.0, '2 viral nonstructural genes') 
(63763.0, 'virus antigen expression studies') 
(63762.0, '1 x 1 ()') 
(63759.0, 'small viral protein') 
(63754.0, '1 transformed cells') 
(63753.0, '1 cells grown') 
(63742.0, '2 x 1 l') 
(63742.0, '1 antiserum following infection') 
(63739.0, 'human avian influenza virus') 
(63727.0, 'human papilloma virus 4') 
(63727.0, '1 monkey cells') 
(63726.0, 'virus protein interactions') 
(63722.0, '1 x lo6 1') 
(63718.0, '1 pneumocytes cells accompanied') 
(63716.0, 'respiratory disease syndrome virus') 
(63715.0, 'dengue virus 1') 
(63712.0, 'splenic cd11c 1 cells') 
(63704.0, '1 hi cells') 
(63698.0, 'viral rna could readily') 
(63696.0, 'proteins control viral replication') 
(63693.0, 'sense viral rna could') 
(63677.0, 'helper 1 cells') 
(63676.0, '1 step 1') 
(63659.0, 'detect virus protein') 
(63656.0, '1 monocyte cells') 
(63646.0, 'daily human infection data') 
(63638.0, 'human influenza virus h1n1') 
(63632.0, 'standard 2 sector cells') 
(63632.0, 'host cell infection cycle') 
(63627.0, 'infected cells could') 
(63624.0, 'study human infection due') 
(63620.0, 'potential virus infection') 
(63593.0, 'viral protein production exerted') 
(63571.0, '1 counteracts viral fusion') 
(63568.0, 'm2 viral surface protein') 
(63567.0, 'isolate human influenza virus') 
(63561.0, 'pk 1 cells') 
(63552.0, 'regulating respiratory viral infection') 
(63542.0, 'infected human cell line') 
(63542.0, 'human infected cell line') 
(63538.0, 'ebola virus envelope protein') 
(63532.0, '1 ͑ n 2') 
(63520.0, '1 cells transduced') 
(63519.0, 'cell types following infection') 
(63511.0, 'respiratory viral infection acting') 
(63511.0, '1 versus 1') 
(63506.0, 'viral early protein') 
(63498.0, 'human b cells express') 
(63497.0, '1 overexpressing cells') 
(63494.0, 'two distinct viral strains') 
(63489.0, 'human immune deficiency virus') 
(63481.0, 'viral infection group seemed') 
(63471.0, 'related virus infection') 
(63469.0, 'cell membrane protein extracts') 
(63469.0, '1 virus lacking') 
(63465.0, '1 virus experienced') 
(63464.0, 'host cell allows infection') 
(63461.0, 'target viral protein') 
(63460.0, 'virus infection might') 
(63456.0, 'viral protein structure') 
(63450.0, 'virus production 2') 
(63433.0, 'hendra virus f protein') 
(63427.0, 'new castle disease virus') 
(63427.0, '2 infections among patients') 
(63425.0, 'sendai virus f protein') 
(63425.0, '1 ∶ 1 ratio') 
(63421.0, 'cd11c 1 cells') 
(63413.0, 'rna virus proteins') 
(63410.0, 'viral respiratory disease caused') 
(63410.0, '1 cells intravenously') 
(63406.0, 'nonspecific cell protein antibodies') 
(63406.0, '1 cells pulsed') 
(63401.0, '1 viral particles') 
(63398.0, 'west nile virus 1') 
(63389.0, 'viral protein function') 
(63389.0, 'seasonal human influenza virus') 
(63389.0, 'human seasonal influenza virus') 
(63379.0, '3 control cells') 
(63376.0, 'infect human b cells') 
(63375.0, 'ilarvirus 2 b protein') 
(63370.0, 'cells underwent cell death') 
(63368.0, '1 protein revealed') 
(63365.0, '1 monocytic cells') 
(63362.0, 'human immune cells') 
(63361.0, 'two model cell lines') 
(63354.0, 'viral protein production') 
(63317.0, 'virus protein synthesis') 
(63314.0, 'human cell lines infected') 
(63304.0, 'viral protein e') 
(63304.0, 'viral e protein') 
(63304.0, 'e viral protein') 
(63303.0, '10 3 cells') 
(63299.0, 'ah 1 cells') 
(63297.0, 'dengue virus envelope protein') 
(63291.0, 'measles virus ha protein') 
(63268.0, '1 cells thril') 
(63266.0, '2 specific immune response') 
(63259.0, 'herpes simplex virus 1') 
(63259.0, 'herpes simplex 1 virus') 
(63258.0, 'two virus strains') 
(63258.0, 'cos41 1 cells') 
(63255.0, 'cells 1') 
(63255.0, '1 cells') 
(63254.0, 'viral surface protein m1') 
(63240.0, '1 mred fusion protein') 
(63234.0, '1 fusion protein') 
(63227.0, 'least one respiratory virus') 
(63219.0, 'structural protein 1') 
(63213.0, 'viral infection model') 
(63205.0, 'associated viral infection') 
(63201.0, 'serotype 1 virus') 
(63199.0, 'viral 3 rna') 
(63194.0, 'positive human microglial cells') 
(63182.0, 'human host cells') 
(63182.0, 'based protein expression systems') 
(63167.0, 'including several viral diseases') 
(63159.0, 'passage 1 virus') 
(63156.0, 'protein structure model could') 
(63148.0, 'day 2 following infection') 
(63143.0, 'cov viral protein') 
(63141.0, 'human respiratory cells') 
(63141.0, 'described two human patients') 
(63135.0, '1 three different strategies') 
(63132.0, 'pathogens including influenza virus') 
(63127.0, '226 viral infection samples') 
(63125.0, 'two different influenza viruses') 
(63093.0, 'human memory b cells') 
(63089.0, '1 infection induced') 
(63074.0, 'bovine viral diarrhoea virus') 
(63069.0, 'total viral protein') 
(63063.0, 'γ 2 p 1') 
(63062.0, 'particular virus protein') 
(63061.0, 'clade 1 virus') 
(63060.0, 'cell surface receptors cell') 
(63057.0, 'identified cell attachment protein') 
(63052.0, 'human immunodeficiency virus antibody') 
(63050.0, 'nipah virus v protein') 
(63050.0, '1 · 1') 
(63046.0, 'infection control intervention 2') 
(63034.0, '80 different viral proteins') 
(63021.0, 'viral infection group') 
(63007.0, 'human influenza virus season') 
(63000.0, 'specific gene expression data') 
(62987.0, 'cells increased disease') 
(62980.0, 'uncomplicated viral respiratory infection') 
(62968.0, 'factors including virus strain') 
(62967.0, 'viral infection cases') 
(62960.0, 'xiong 1 1 university') 
(62953.0, 'one treated host cells') 
(62951.0, 'including two new studies') 
(62921.0, 'viral cell culture represents') 
(62912.0, 'activated protein kinase 1') 
(62911.0, '2 mediated virus attachment') 
(62909.0, 'human pathogenic virus species') 
(62890.0, 'monkey virus 1') 
(62888.0, 'homogeneous virus ([ 1') 
(62874.0, '1 causative virus') 
(62873.0, '1 viral attachment step') 
(62872.0, 'respiratory virus could affect') 
(62864.0, 'different viral proteins instead') 
(62860.0, 'inhibit viral protein synthesis') 
(62844.0, 'concentrations ofaqp 1 protein') 
(62842.0, 'gha1 viral surface protein') 
(62836.0, 'viral surface protein') 
(62832.0, 'let say virus 1') 
(62829.0, '2 alveolar epithelial cells') 
(62817.0, '1 μl dharmafect 1') 
(62810.0, 'human hepatitis b virus') 
(62789.0, '3 2b4 cells used') 
(62787.0, 'adquired respiratory viral infection') 
(62785.0, '1 nucleocapsid protein 19') 
(62783.0, 'viral respiratory infection') 
(62783.0, 'respiratory viral infection') 
(62766.0, '10 5 susceptible cells') 
(62763.0, '1 promoting viral release') 
(62757.0, 'common cold virus infection') 
(62741.0, 'parainfluenza virus 1') 
(62737.0, '1 tar rna rna') 
(62736.0, 'production upon viral infection') 
(62732.0, 'viral rna could') 
(62730.0, '3 viral proteins anchored') 
(62729.0, 'cell numbers following infection') 
(62729.0, '3 x10 4 cells') 
(62728.0, '5 infected vero cells') 
(62712.0, 'human cell culture samples') 
(62701.0, 'wuhan aphid virus 1') 
(62693.0, 'day 1 post infection') 
(62693.0, '1 day post infection') 
(62687.0, 'influenza virus disease severity') 
(62685.0, 'two influenza proteins based') 
(62682.0, 'human influenza virus replicates') 
(62676.0, 'viral rna sequences without') 
(62674.0, '2 ], hendra virus') 
(62673.0, '5 3 10 5') 
(62659.0, 'chimera virus 1') 
(62655.0, 'viral fusion protein synthesized') 
(62651.0, 'negative strand virus infection') 
(62639.0, 'viral rna via binding') 
(62639.0, '1 plus azithromycin 1') 
(62623.0, 'viral rna replication analysis') 
(62623.0, 'interpret cell virus interactions') 
(62604.0, 'viral respiratory disease outbreak') 
(62603.0, '2 shrna treated cells') 
(62592.0, 'human cells results') 
(62588.0, 'human chronic virus important') 
(62586.0, 'human respiratory syncytial virus') 
(62564.0, 'human gene sequence data') 
(62563.0, 'viral infection might result') 
(62561.0, '1 infection compared') 
(62560.0, '2 recombinant virus') 
(62559.0, 'virus protein database') 
(62558.0, 'either virus infection') 
(62545.0, 'influenza viral infection') 
(62541.0, 'southwest baboon virus 1') 
(62534.0, 'virus cell interactions') 
(62532.0, '1 3 10 26') 
(62526.0, '2 cells occurs') 
(62523.0, 'cell bone marrow cells') 
(62519.0, '3 viral proteins') 
(62511.0, 'h1n1 viral infection compared') 
(62508.0, 'human naïve b cells') 
(62506.0, '2 protein sequences') 
(62502.0, 'sabin 1 virus') 
(62501.0, 'least two virus types') 
(62485.0, '1 ): 1') 
(62482.0, 'lymphotropic virus 1') 
(62479.0, 'reduced viral gene expression') 
(62471.0, 'first human immunodeficiency virus') 
(62459.0, 'human h3n2 influenza virus') 
(62456.0, 'handling human b cells') 
(62455.0, 'virus 1 inability') 
(62452.0, 'helper cell type 2') 
(62448.0, 'containing protein 2') 
(62440.0, '1 1 nucleotides') 
(62438.0, 'breda virus 1') 
(62432.0, 'zambian malbrouck virus 1') 
(62431.0, 'homalodisca coagulate virus 1') 
(62431.0, 'formica exsecta virus 1') 
(62430.0, 'protein around 1') 
(62426.0, 'virus }\\; 1 )}(') 
(62425.0, '2 protein production despite') 
(62424.0, 'viral proteins including ha') 
(62421.0, 'tuhoko virus 1') 
(62421.0, 'parinfluenza virus 1') 
(62420.0, 'type 2 cell hyperplasia') 
(62419.0, 'lungs following viral infection') 
(62418.0, 'virus 1') 
(62418.0, '1 virus') 
(62416.0, 'utilize human b cells') 
(62415.0, 'multidrug resistance protein 1') 
(62407.0, 'virus cell entry') 
(62401.0, 'human influenza virus h1') 
(62397.0, 'internal virus protein') 
(62395.0, 'cell surface protein amounts') 
(62394.0, 'including respiratory epithelial cells') 
(62380.0, '1 h 2') 
(62366.0, 'viruses like influenza virus') 
(62355.0, 'human virus levels') 
(62354.0, 'human immunodeficiency virus infections') 
(62350.0, '1 cell growth') 
(62304.0, 'human respiratory virus') 
(62303.0, 'diluted 1 ∶ 1') 
(62301.0, '2 0 3 0') 
(62300.0, 'specific b cells isolated') 
(62295.0, 'viral nervous necrosis virus') 
(62295.0, 'ebola virus disease treatment') 
(62290.0, 'viral spike protein produced') 
(62290.0, '1 protein interactions') 
(62283.0, '1 ¼ 1') 
(62281.0, 'g virus particle infection') 
(62268.0, '2 pfu per cell') 
(62264.0, '1 k − 2') 
(62261.0, 'virus infection 7') 
(62258.0, '1 ligand 1') 
(62255.0, 'various virus infection') 
(62251.0, '1 cell lines express') 
(62249.0, 'viral protein database indicated') 
(62249.0, '1 virions 1') 
(62247.0, '2 cells treated') 
(62234.0, 'viral infection results') 
(62232.0, 'human influenza virus pr8') 
(62230.0, 'essential virus protein') 
(62229.0, 'human viral challenge model') 
(62215.0, 'arise without viral infection') 
(62213.0, '2 cells free') 
(62207.0, 'rubella virus envelope protein') 
(62206.0, 'chronically infected cells including') 
(62193.0, 'ebola virus vp35 protein') 
(62191.0, 'related protein 2') 
(62191.0, '2 related protein') 
(62188.0, 'promote viral protein synthesis') 
(62167.0, '1 1 shared') 
(62166.0, 'human b1 b cells') 
(62159.0, 'mouth disease virus c') 
(62159.0, '1 panel 1') 
(62153.0, 'cov infection drives cells') 
(62151.0, 'take 1 1') 
(62151.0, 'bacterial infection represents 1') 
(62144.0, 'human primary cells tested') 
(62139.0, 'viral cell receptor') 
(62127.0, 'human lung epithelial cells') 
(62126.0, 'viral rna specific') 
(62126.0, 'specific viral rna') 
(62125.0, 'two human dna genes') 
(62124.0, 'transactivating viral protein factor') 
(62124.0, '1 2 p') 
(62103.0, 'ebola virus vp24 protein') 
(62103.0, '1 cell decreased') 
(62101.0, 'viral envelop proteins could') 
(62084.0, 'mouseadapted human influenza virus') 
(62084.0, 'chimaeric protein formed virus') 
(62082.0, 'first human virus') 
(62072.0, 'human lung cancer cells') 
(62070.0, 'nonadapted human influenza virus') 
(62067.0, 'influenza virus disease phenotypes') 
(62066.0, 'human influenza virus') 
(62063.0, '1 capsid protein inhibits') 
(62056.0, 'reduced upon viral infection') 
(62052.0, 'affect viral protein translation') 
(62051.0, 'pneumococcal cell surface protein') 
(62046.0, 'specific virus titer showed') 
(62046.0, '1 viral inhibition') 
(62041.0, 'activated upon virus infection') 
(62029.0, 'viral structural vp1 protein') 
(62029.0, 'viral structural protein vp1') 
(62020.0, 'evolved specific viral proteins') 
(62012.0, 'virus infection induces hiv') 
(62011.0, 'virus protein 26') 
(62001.0, 'including pabpc proteins 1') 
(61999.0, 'h 1 5 6') 
(61999.0, 'genes regulating viral infection') 
(61997.0, 'norwalk virus capsid protein') 
(61996.0, 'following neurotropic viral infection') 
(61993.0, 'virus late gene expression') 
(61992.0, 'viral rdrp recognizes virus') 
(61978.0, 'several influenza virus strains') 
(61974.0, 'dengue virus ns5 protein') 
(61973.0, 'cell virus spread') 
(61970.0, 'structural viral protein 2b') 
(61965.0, 'human virus infections') 
(61964.0, '2 e 1') 
(61962.0, 'human b cell surface') 
(61959.0, 'immortalize human b cells') 
(61958.0, '1 cases per 10') 
(61953.0, '1 · 2 times') 
(61951.0, 'human b cells') 
(61950.0, 'inhibit viral cell entry') 
(61948.0, 'fusogenic virus spike protein') 
(61947.0, 'human primary cells isolated') 
(61945.0, 'cd8 cells among patients') 
(61939.0, 'cov infected host cells') 
(61937.0, '10 5 vero cells') 
(61931.0, '10 5 viable cells') 
(61928.0, 'cell surface protein fused') 
(61919.0, 'virus gene expression profile') 
(61914.0, 'infected cells 5') 
(61914.0, '5 cells infected') 
(61902.0, '2 inference method 1') 
(61898.0, '3 cells increased') 
(61894.0, 'viral infectious diseases could') 
(61877.0, 'virus protein responsible') 
(61877.0, 'common adventitious virus infection') 
(61867.0, 'bat cell virus') 
(61865.0, 'new virus could') 
(61865.0, 'chimeric coat protein virus') 
(61856.0, '1 1 department') 
(61847.0, 'inhibit viral protein translation') 
(61844.0, 'without viral infection') 
(61837.0, 'inhibits viral protein synthesis') 
(61829.0, 'deregulated following viral infection') 
(61817.0, 'studies high virus growth') 
(61816.0, 'cam 2 cells expressing') 
(61815.0, 'abundant viral protein produced') 
(61798.0, 'following viral infection') 
(61795.0, 'viral protein mrna') 
(61785.0, 'viral rev protein whereas') 
(61771.0, 'enhance viral protein synthesis') 
(61765.0, 'structural viral protein ns5') 
(61756.0, 'virus attachment protein embedded') 
(61749.0, 'acute pulmonary viral infection') 
(61739.0, 'including virus expression') 
(61732.0, 'viral respiratory disease outbreaks') 
(61732.0, 'examined viral protein synthesis') 
(61725.0, 'influenza type c virus') 
(61722.0, '1 ≤ 1') 
(61713.0, 'human herpes virus 6') 
(61713.0, '2 cells expressing') 
(61700.0, 'productive sars virus infection') 
(61692.0, 'drosophila line 2 cells') 
(61691.0, 'human hepatic cells via') 
(61657.0, 'virus lung infection') 
(61652.0, 'viral protein r') 
(61652.0, 'different viral proteins') 
(61650.0, '5 cells per well') 
(61648.0, 'viral cell culture supernatant') 
(61647.0, '1 viral cycle') 
(61643.0, '1 ae 1') 
(61640.0, 'viral antigenpositive cells') 
(61640.0, 'human red blood cells') 
(61639.0, '2 human samples available') 
(61636.0, 'viral hemorrhagic septicemia virus') 
(61636.0, 'one important human disease') 
(61634.0, '1 þ 1') 
(61612.0, 'viral fusion protein') 
(61610.0, 'cells reduced chronic disease') 
(61601.0, '2 n protein') 
(61599.0, 'infected cells three times') 
(61597.0, 'viral structural protein') 
(61597.0, 'structural viral protein') 
(61590.0, 'total cell protein') 
(61583.0, 'virus rna replication complex') 
(61583.0, 'cell fusing agent virus') 
(61575.0, 'viral protein concentration') 
(61573.0, 'cells possessed chmda5 protein') 
(61557.0, 'published virus binding data') 
(61552.0, 'two protein samples') 
(61545.0, '2 viral replication') 
(61535.0, 'vaccinia virus e3 protein') 
(61524.0, 'produce abundant viral protein') 
(61523.0, 'virus m2 protein illustrates') 
(61521.0, '2 x 106 cells') 
(61519.0, '2 cells resulted') 
(61507.0, 'vaccinia virus inhibits cell') 
(61498.0, 'cells every 2') 
(61472.0, 'control influenza virus replication') 
(61470.0, 'two human influenza strains') 
(61454.0, 'primary virus infection') 
(61454.0, 'primary infection virus') 
(61446.0, 'specific viral proteins') 
(61441.0, 'viruses including marburg virus') 
(61435.0, 'viral rna since treatment') 
(61428.0, '2 l viral cdna') 
(61419.0, 'functional viral protein') 
(61398.0, 'cell wall contains 1') 
(61396.0, 'immune cells including macrophages') 
(61393.0, 'target viral rna sequence') 
(61389.0, 'detected viral icp4 protein') 
(61388.0, 'acute virus infection') 
(61386.0, '8 cell infection assays') 
(61380.0, '1 lymphoma cell line') 
(61375.0, 'severe rna viral infections') 
(61367.0, 'immune cells could interfere') 
(61366.0, 'igsf cell surface protein') 
(61364.0, 'high viral load could') 
(61359.0, '1 )] 1') 
(61357.0, 'cell surface protein') 
(61354.0, 'human immunodeficiency virus type') 
(61347.0, 'among several viral infections') 
(61345.0, 'host cell infection') 
(61328.0, 'virus attachment protein') 
(61324.0, 'mediated dengue virus infection') 
(61316.0, 'ebola virus disease compared') 
(61301.0, '1 1 allergy') 
(61296.0, 'protein ratio 1') 
(61281.0, 'detect influenza virus rna') 
(61271.0, 'viral protein structures') 
(61269.0, '2 e protein recognized') 
(61269.0, '1 +, 1') 
(61267.0, '1 reaches 1') 
(61261.0, 'including dna virus vectors') 
(61260.0, '5 days per 1') 
(61257.0, 'different host cell systems') 
(61255.0, 'like protein 2') 
(61255.0, 'like 2 protein') 
(61250.0, '1 ∶ 1 mixes') 
(61247.0, '1 ∶ 1 acetonitrile') 
(61244.0, 'given viral protein') 
(61241.0, '1 (≤ 1 cyst') 
(61237.0, 'influenza b virus infections') 
(61229.0, 'autophagy upon virus infection') 
(61228.0, 'sars virus infection') 
(61228.0, '10 5 cells plated') 
(61221.0, '2 acute respiratory disease') 
(61216.0, '1 (± 1') 
(61202.0, '1 ∶ 1') 
(61195.0, '1 mm mgcl 2') 
(61194.0, '10 5 k562 cells') 
(61189.0, 'several human cell lines') 
(61186.0, 'rubella virus nonstructural protein') 
(61186.0, '1 1 immunology') 
(61182.0, '1 ′), 1') 
(61180.0, 'mouth virus vp1 protein') 
(61179.0, '1 expression remains high') 
(61178.0, '1 versus 2 specimens') 
(61174.0, '1 (+ 1') 
(61173.0, 'infection rate βαλ 1') 
(61161.0, 'vaccinia virus protein e3l') 
(61156.0, 'lipid protein 1') 
(61147.0, 'virus infection models') 
(61147.0, '1 mm cacl 2') 
(61142.0, '10 5 ld652 cells') 
(61136.0, 'different viruses 1') 
(61130.0, 'vaccinia virus protein a49') 
(61128.0, 'tagged viral protein plasmid') 
(61128.0, '1 ([ 1') 
(61123.0, '10 5 cells') 
(61113.0, 'including viral rna encapsidation') 
(61112.0, 'hendra virus protein sg') 
(61107.0, '1 mm mncl 2') 
(61104.0, 'infected cells showed evidence') 
(61102.0, 'elim 1 2 values') 
(61099.0, '1 mm cocl 2') 
(61096.0, 'positive mononuclear cells could') 
(61092.0, '2 shows two cases') 
(61090.0, '1 /( 1') 
(61089.0, '2 mm 1') 
(61089.0, '1 mm 2') 
(61086.0, '1 viral particle') 
(61078.0, 'mammalian reovirus 1 protein') 
(61077.0, 'virus ns1 protein') 
(61066.0, 'jack johnson 1 1') 
(61056.0, 'medium throughout virus infection') 
(61039.0, '1 1 pediatrics') 
(61035.0, 'rna viral rna') 
(61033.0, '1 -[( 1') 
(61025.0, 'zika virus protein') 
(61020.0, 'residual respiratory disease 1') 
(61019.0, '1 ’), 1') 
(61017.0, 'different host virus families') 
(61007.0, 'bär 1 1 inst') 
(61002.0, '1 +( 1') 
(60992.0, '1 ):( 1') 
(60989.0, '1 1 b9') 
(60988.0, '1 –( 1') 
(60987.0, 'viral spike protein indicate') 
(60987.0, '1 viral load') 
(60985.0, 'rudinsky 1 1') 
(60985.0, '1 −[ 1') 
(60985.0, '1 }{( 1') 
(60984.0, 'vascular adhesion protein 1') 
(60982.0, '1 1') 
(60980.0, 'total viral rna levels') 
(60969.0, '1 grouper cell line') 
(60963.0, 'time viral rna test') 
(60963.0, 'every j 2 1') 
(60951.0, 'includes pneumonia virus infection') 
(60948.0, '2 · 1 million') 
(60944.0, '3 novel viral species') 
(60941.0, 'virus vp1 protein') 
(60939.0, 'viral infection compared') 
(60939.0, '145 cells upon infection') 
(60935.0, 'including virus control wells') 
(60932.0, '1 cell line') 
(60929.0, 'new influenza virus genome') 
(60925.0, 'primary human airway cells') 
(60922.0, '2 cm − 1') 
(60910.0, 'chain positive rna virus') 
(60909.0, 'two human cases related') 
(60905.0, 'virus protein lysate') 
(60878.0, 'one viral rna') 
(60876.0, 'virus hemagglutinin protein') 
(60864.0, 'specific igg 1 response') 
(60858.0, 'lymphocyte cytosolic protein 1') 
(60857.0, '2 enhances viral antigen') 
(60855.0, 'memory b cells could') 
(60854.0, 'sendai virus f1 protein') 
(60850.0, '1 encoded accessory protein') 
(60847.0, '2 ml 1') 
(60847.0, '1 ml 2') 
(60840.0, 'virus strains could result') 
(60833.0, 'reduced virus production could') 
(60829.0, 'viral mediated cell hijacking') 
(60829.0, 'human cells expressing hiv') 
(60800.0, '2 protein level') 
(60788.0, 'viral ha protein binds') 
(60786.0, 'initiate viral protein synthesis') 
(60778.0, 'following st cell infection') 
(60769.0, 'specificity protein 1') 
(60765.0, 'viral protein synthesis initiated') 
(60761.0, 'two b cell epitopes') 
(60755.0, 'virus protein expressions') 
(60743.0, 'generated two cells lines') 
(60742.0, 'initiates cell death 1') 
(60738.0, 'human gene expression studies') 
(60737.0, 'one protein coding gene') 
(60732.0, 'cells (" cell division') 
(60728.0, 'cells upon infection') 
(60724.0, 'different immune cells') 
(60724.0, '2 virus better') 
(60722.0, 'positive cells could') 
(60717.0, 'viral genotype 1') 
(60715.0, 'matrix protein 1') 
(60714.0, '4 2 4 4') 
(60712.0, 'virus infection process') 
(60709.0, 'novel virus infection') 
(60704.0, '1 cell lines') 
(60701.0, 'rotavirus nonstructural protein 1') 
(60699.0, 'least one control cell') 
(60690.0, 'viral infection include sinusitis') 
(60689.0, 'programmed cell death 1') 
(60688.0, 'known virus specific h') 
(60686.0, '2 receptor interacting protein') 
(60682.0, 'viral target host proteins') 
(60676.0, 'different cell lines infected') 
(60668.0, 'viral protein interactions') 
(60667.0, '2 infection showed') 
(60657.0, 'least two human viruses') 
(60645.0, 'viral infection might interfere') 
(60645.0, 'rna virus vaccine vectors') 
(60641.0, 'viral protein overexpression approaches') 
(60639.0, 'study rna virus evolution') 
(60626.0, '1 spoton flow cell') 
(60613.0, 'cell sorting 1536 cells') 
(60611.0, 'block viral protein translation') 
(60609.0, 'one protein including') 
(60608.0, '1 cm 3 samples') 
(60608.0, '1 associated disease') 
(60600.0, '2 %); type 2') 
(60593.0, 'two virus types occurred') 
(60591.0, 'influenza virus infections due') 
(60585.0, 'reduced viral rna levels') 
(60573.0, 'viral disease control') 
(60572.0, 'cell cultured virus gd') 
(60567.0, 'viral protein interaction') 
(60564.0, '1 envelope protein') 
(60562.0, 'cell without csfv infection') 
(60555.0, 'key viral protein') 
(60552.0, 'viral d12 protein 25') 
(60552.0, 'entire viral capsid protein') 
(60549.0, 'include viral infection') 
(60547.0, 'subsequent viral gene expression') 
(60542.0, '2 data data packets') 
(60540.0, '3 protein expression') 
(60535.0, 'denv nonstructural protein 1') 
(60526.0, '2 virus isolates') 
(60518.0, 'specific immune cells') 
(60514.0, '2 %, 1') 
(60514.0, '1 %, 2') 
(60513.0, 'viral protein fragments displayed') 
(60511.0, 'influenza virus could indeed') 
(60509.0, 'virus protein') 
(60508.0, 'impair viral protein synthesis') 
(60505.0, '21 cells inhibited infection') 
(60499.0, 'human cells via') 
(60499.0, 'different influenza virus subtypes') 
(60495.0, 'recombinant virus infection') 
(60488.0, 'cell free viral stocks') 
(60485.0, '1 capsid protein') 
(60484.0, '1 env protein folding') 
(60480.0, 'initial measles virus infection') 
(60478.0, 'autophagy protein beclin 1') 
(60477.0, 'human lung stem cells') 
(60475.0, 'virus infection must') 
(60449.0, 'immune cells including dc') 
(60448.0, 'wt infection protein 7') 
(60447.0, 'viral rna remodelling proteins') 
(60445.0, 'viruses require viral proteins') 
(60440.0, '1 viral infectivity') 
(60428.0, 'two virus groups') 
(60424.0, 'acute viral infection syndrome') 
(60406.0, 'detect viral gene expression') 
(60402.0, 'viral infection might') 
(60400.0, 'virus could cross species') 
(60400.0, '1 1241 aa protein') 
(60396.0, 'three viral structural proteins') 
(60395.0, 'newly synthesized viral protein') 
(60381.0, 'including hepatitis c virus') 
(60380.0, 'viral protein functions') 
(60379.0, '1 viral proteases') 
(60377.0, 'e c 2 3') 
(60373.0, 'including viral proteins') 
(60369.0, 'white cell count 1') 
(60363.0, 'hepatitis c virus rna') 
(60355.0, 'rna viral proteins') 
(60343.0, 'dengue virus infection show') 
(60342.0, '1 particle cell gave') 
(60322.0, 'virus analysis could') 
(60321.0, 'virus infection conditions') 
(60319.0, 'following cell infection') 
(60315.0, '3 infected cell membranes') 
(60315.0, '1 h infection') 
(60314.0, 'virus gene expression') 
(60298.0, '2 hours following infection') 
(60295.0, 'least one human disease') 
(60265.0, 'several different virus') 
(60263.0, 'influenza infected cells revealed') 
(60259.0, 'viral protein synthesis') 
(60258.0, 'primary viral infection leads') 
(60255.0, 'virus infectious diseases infected') 
(60253.0, '1 %), piv 2') 
(60249.0, 'specific memory b cells') 
(60247.0, 'viral f protein') 
(60237.0, 'type b influenza virus') 
(60237.0, 'influenza virus type b') 
(60237.0, 'influenza virus b type') 
(60237.0, 'b type influenza virus') 
(60235.0, 'group 7 control 1') 
(60233.0, 'persistent human viral infections') 
(60220.0, '3 include virus isolation') 
(60216.0, '1 induced disease resolution') 
(60214.0, 'ebola virus disease reported') 
(60201.0, 'mitochondria upon virus infection') 
(60200.0, 'two viral strains') 
(60194.0, 'virus sequence data met') 
(60189.0, 'remodeling upon virus infection') 
(60186.0, '1 respiratory disease') 
(60184.0, 'cell surface binding data') 
(60175.0, '1 acute hav infection') 
(60171.0, 'hcv viral protein ns5b') 
(60168.0, '1 viral preparations') 
(60159.0, 'glutamate rich 1 protein') 
(60155.0, 'two different recombinant proteins') 
(60154.0, 'viral protein x') 
(60141.0, 'viral infection via') 
(60140.0, '1 ‐ 2') 
(60137.0, 'whole virus infection cycle') 
(60136.0, 'two additional viral targets') 
(60133.0, 'include viral rna replication') 
(60123.0, 'two inactivated virus vaccines') 
(60121.0, 'virion protein 1') 
(60121.0, '2 0 5 0') 
(60119.0, 'human type 1 diabetes') 
(60102.0, 'n protein expression levels') 
(60091.0, 'plant viral coat protein') 
(60090.0, 'dengue virus infection causes') 
(60078.0, 'determine viral protein accumulation') 
(60075.0, 'used two different species') 
(60074.0, 'two specific genes used') 
(60074.0, 'drosophila cells 3 genes') 
(60067.0, 'human herpesvirus type 1') 
(60066.0, 'respiratory virus could') 
(60062.0, '2 infection increased') 
(60051.0, '1 viral loads') 
(60034.0, 'two viral genes') 
(60029.0, 'associated respiratory viral infections') 
(60026.0, 'prevent viral gene expression') 
(60022.0, 'evaluate virus specific response') 
(60010.0, 'among viral pneumonia patients') 
(60004.0, 'particular viral protein') 
(60001.0, 'different virus internal genes') 
(59991.0, 'increased influenza virus replication') 
(59986.0, 'affects viral infection significantly') 
(59982.0, 'restricting initial virus infection') 
(59982.0, 'derived human adult cells') 
(59973.0, 'viral protein components') 
(59973.0, 'obtain sufficient viral protein') 
(59970.0, 'actin patch protein 1') 
(59969.0, 'whole cell viral transcripts') 
(59964.0, '2 infection model') 
(59951.0, 'two virus models') 
(59948.0, 'three different cell types') 
(59944.0, '2 cells apoptosis') 
(59925.0, 'secondary den virus infection') 
(59922.0, '2 cells depends') 
(59918.0, 'human immunodeficiency type 1') 
(59918.0, 'among viral structural proteins') 
(59906.0, '2 virus titers') 
(59900.0, 'viral nuclear export protein') 
(59900.0, 'four different viral diseases') 
(59893.0, 'studied viral 62 protein') 
(59891.0, 'upon virus infection') 
(59887.0, 'zika virus infection remains') 
(59886.0, 'viral protein targets') 
(59885.0, 'times 1 2') 
(59882.0, 'type 2 prrsv infection') 
(59868.0, '1 nucleocapsid protein p7') 
(59865.0, 'active sendai virus infection') 
(59861.0, '1 infected patients') 
(59859.0, 'human primary endothelial cells') 
(59853.0, 'macrophage inflammatory protein 2') 
(59843.0, '1 env protein') 
(59838.0, 'cell leukemia virus') 
(59828.0, 'influenza virus could') 
(59825.0, 'new protein sequences associated') 
(59821.0, 'cell help 1') 
(59819.0, 'virus specific antibody') 
(59817.0, '1 viral gp120') 
(59814.0, 'specific infection sequences associated') 
(59797.0, 'virus sequence data') 
(59790.0, 'ebola virus disease since') 
(59778.0, 'viral protein cleavage') 
(59778.0, 'recruit protein phosphatase 1') 
(59778.0, 'primary human nk cells') 
(59773.0, 'initiate viral protein translation') 
(59772.0, '3 h virus exposure') 
(59771.0, 'since human cells') 
(59769.0, 'chronic virus infection') 
(59768.0, 'nk cells specific genes') 
(59765.0, 'cov eng 1 infection') 
(59762.0, 'like receptor protein 3') 
(59754.0, 'viral rna based') 
(59753.0, '1 accessory protein vpu') 
(59745.0, 'active virus infection') 
(59745.0, '1 gag protein') 
(59741.0, 'including cell toxic proteins') 
(59736.0, 'expressing cells via one') 
(59732.0, 'protein expression data') 
(59729.0, 'first dna virus genome') 
(59727.0, 'virus infections could') 
(59726.0, 'human herpesviruses type 1') 
(59725.0, 'respiratory virus data') 
(59724.0, 'cell culturederived virus stocks') 
(59722.0, 'containing virus structural proteins') 
(59721.0, 'specific viral strains included') 
(59718.0, 'virus genome identified based') 
(59713.0, 'b cells could') 
(59704.0, 'decreased virus infection') 
(59701.0, 'viral strain causes disease') 
(59682.0, 'human bocavirus type 1') 
(59678.0, '2 μm protein concentration') 
(59677.0, 'interacting protein 1') 
(59667.0, 'high viral rna load') 
(59663.0, '2 − 1') 
(59663.0, '1 − 2') 
(59657.0, 'predicted viral protein') 
(59650.0, 'human cell system') 
(59644.0, 'positive strand rna virus') 
(59628.0, 'two copies per cell') 
(59627.0, 'dengue virus serotype 2') 
(59619.0, '1 cell j') 
(59613.0, 'disease virus genome load') 
(59600.0, '1 accessory protein') 
(59593.0, 'viral attachment protein spike') 
(59585.0, 'several dengue virus proteins') 
(59577.0, '1 week post infection') 
(59573.0, 'virus infection whereas') 
(59572.0, 'monocyte chemotactic protein 1') 
(59563.0, 'human lung carcinoma cells') 
(59559.0, 'multiple viral infection') 
(59559.0, 'liver upon viral infection') 
(59558.0, 'peripheral viral infection models') 
(59554.0, 'midgut epithelial cells infection') 
(59551.0, 'examine viral protein dynamics') 
(59548.0, 'virus causing cns infection') 
(59548.0, 'recombinant protein expression system') 
(59546.0, 'new viral rna genomes') 
(59543.0, 'nonstructural protein 1') 
(59530.0, '1 gp120 protein') 
(59527.0, '1 tat protein conjugates') 
(59525.0, 'monocyte chemoattractant protein 1') 
(59517.0, 'parainfluenza virus type 3') 
(59514.0, 'viral protein transport') 
(59508.0, 'two query protein sequences') 
(59507.0, 'elongation protein zeta 1') 
(59505.0, '2 mammalian expressed protein') 
(59502.0, 'viral ha protein') 
(59501.0, 'viral protein database') 
(59495.0, 'overall virus population health') 
(59491.0, 'epidemic corona virus infection') 
(59490.0, 'dependent protein kinase 2') 
(59488.0, 'random cell barcode 1') 
(59487.0, 'cells produce high levels') 
(59486.0, '2 containing 2') 
(59483.0, 'patients showed disease control') 
(59483.0, '2 rna could') 
(59480.0, 'infection viral replication') 
(59479.0, 'protein phosphatase 1') 
(59478.0, 'viral spike protein rbd') 
(59460.0, 'viral protein unit vpu') 
(59456.0, 'viral infectious disease management') 
(59451.0, 'viral protein processing') 
(59451.0, 'efficient viral gene expression') 
(59450.0, 'tumour protein 1') 
(59450.0, 'protein ligase 1') 
(59445.0, 'including immune cells') 
(59441.0, 'multiple respiratory virus infections') 
(59430.0, 'ebola virus infection appears') 
(59428.0, 'influenza virus different') 
(59428.0, 'different influenza virus') 
(59427.0, '1 tax protein interferes') 
(59426.0, '1 familitur data showed') 
(59405.0, 'activator protein 1') 
(59401.0, '2 colon carcinoma cells') 
(59394.0, 'viral protein tat lead') 
(59392.0, 'viral rna genome via') 
(59391.0, 'infect host cells based') 
(59390.0, 'systemic virus infection plays') 
(59381.0, 'cell lymphotropic virus') 
(59379.0, '2 cells ranged') 
(59375.0, '1 protein belongs') 
(59370.0, 'protein expression based selection') 
(59370.0, 'cells might produce proteins') 
(59366.0, 'studied viral protein') 
(59364.0, 'could inhibit virus replication') 
(59363.0, '1 viral replication39') 
(59353.0, 'type 2 rotavirus infection') 
(59349.0, 'viral cell entry') 
(59349.0, '1 tat protein') 
(59348.0, 'primary human bronchial cells') 
(59330.0, 'h 2 cell chemoattractant') 
(59328.0, 'reported positive virus results') 
(59327.0, 'different virus infections') 
(59327.0, '1 0 − 5') 
(59320.0, 'human herpes virus 7') 
(59319.0, 'directs viral protein translation') 
(59317.0, 'virus cell') 
(59317.0, 'two membrane protein complexes') 
(59316.0, '1 rev protein') 
(59314.0, 'viral nucleocapsid protein encoded') 
(59314.0, '10 4 tumor cells') 
(59311.0, 'viral shedding data 4') 
(59309.0, 'two important viral enzymes') 
(59303.0, 'influenza virus transmission model') 
(59299.0, 'influenza virus rna segments') 
(59292.0, 'infectious bursal disease virus') 
(59287.0, 'high viral rna copies') 
(59285.0, '1 p24 protein') 
(59283.0, 'normal human red cells') 
(59279.0, 'lung tumor cells could') 
(59276.0, '1 infection process') 
(59275.0, 'primary human leukemia cells') 
(59275.0, 'patient 3 developed 1') 
(59267.0, '1 tax protein') 
(59264.0, 'particular chronic viral infection') 
(59262.0, 'human lung a549 cells') 
(59260.0, '2 ): complex 2') 
(59259.0, 'chronic rna viral infections') 
(59258.0, 'similarly infected control cells') 
(59254.0, 'tr 1 protein') 
(59252.0, 'viral protein occurring') 
(59248.0, 'viral n gene sequences') 
(59247.0, 'surfactant protein 1') 
(59246.0, 'viral protein translation') 
(59245.0, 'two protein sequences') 
(59244.0, 'direct virus infection') 
(59239.0, 'human lung fibroblast cells') 
(59231.0, 'n protein domain 3') 
(59230.0, 'different virus genome types') 
(59229.0, 'primary human myeloid cells') 
(59226.0, 'expressing human cancer cells') 
(59222.0, 'specific influenza virus') 
(59217.0, 'immune cells become infected') 
(59216.0, 'confirmed h7n9 virus infection') 
(59215.0, '2 recombinant protein') 
(59202.0, 'influenza virus genome sequence') 
(59198.0, '2 vero cells') 
(59192.0, 'viral titers upon infection') 
(59189.0, 'virus matrix 2') 
(59182.0, 'influenza virus rna varied') 
(59177.0, 'viral nucleocapsid protein np') 
(59177.0, 'relative viral rna levels') 
(59177.0, '1 ϫ 10 5') 
(59176.0, 'including memory b cells') 
(59172.0, 'essential viral protein') 
(59165.0, 'first two infection experiments') 
(59160.0, 'viral fiber protein binds') 
(59158.0, 'virus infection resulting') 
(59155.0, 'measured viral gene expression') 
(59154.0, 'viral cell receptors') 
(59154.0, 'cell viral receptors') 
(59149.0, 'positive sense rna virus') 
(59147.0, 'associated protein levels following') 
(59146.0, '1 vpr protein') 
(59143.0, 'primary human cells implicated') 
(59140.0, 'beclin 1 protein') 
(59137.0, 'zona occludens protein 1') 
(59134.0, 'least one virus identified') 
(59134.0, 'cells revealed n gene') 
(59133.0, 'swine fever virus infection') 
(59130.0, 'viral late protein') 
(59129.0, 'stranded positive rna virus') 
(59128.0, 'palmitoylated protein 1') 
(59127.0, '2 virus variant') 
(59123.0, '1 jrfl gp140 protein') 
(59121.0, 'specific virus infections') 
(59108.0, 'ebna 1 protein') 
(59107.0, 'specific b cells') 
(59107.0, 'b cells specific') 
(59104.0, '1 cell injection') 
(59103.0, 'experimental nipah virus infection') 
(59102.0, 'human lung adenocarcinoma cells') 
(59099.0, '1 vp22 protein') 
(59097.0, 'novel human viral pathogens') 
(59094.0, 'require direct viral infection') 
(59093.0, 'viral protein located') 
(59093.0, 'viral matrix protein') 
(59091.0, 'human cell line per') 
(59087.0, '1 ncp7 protein') 
(59085.0, 'highly contagious viral infection') 
(59083.0, 'white blood cells could') 
(59079.0, 'various respiratory virus infections') 
(59078.0, 'viral protein load') 
(59076.0, '1 nucleocapside protein') 
(59073.0, 'protein 1') 
(59073.0, '1 protein') 
(59069.0, 'viral protein 35') 
(59069.0, '5 1 10 03') 
(59057.0, 'viral gene expression impact') 
(59050.0, 'fc ]× 2 cells') 
(59048.0, 'coronavirus virus infection') 
(59036.0, 'primary human fibroblast cells') 
(59032.0, 'viral filtration activity could') 
(59020.0, 'two target cell populations') 
(59020.0, '5 1 10 04') 
(59011.0, 'human lung fibroblastic cells') 
(59000.0, '2 virus titer') 
(58995.0, 'including c 2 test') 
(58993.0, 'virus specific response') 
(58990.0, '2 carcinoma cells') 
(58988.0, 'primary human microglial cells') 
(58988.0, 'human primary microglial cells') 
(58966.0, 'viral protein ns6 pro') 
(58963.0, 'epidemic viral infection throughout') 
(58959.0, 'c protein could help') 
(58957.0, 'human lung cells') 
(58956.0, '1 mrna expression levels') 
(58955.0, 'two leukaemia virus vaccines') 
(58942.0, 'viral envelope protein') 
(58941.0, 'major viral proteins include') 
(58940.0, 'minimum viral protein requirement') 
(58937.0, 'human primary cells 116') 
(58935.0, 'viral late gene expression') 
(58935.0, 'late viral gene expression') 
(58923.0, 'indicate secondary viral infection') 
(58923.0, '1 icp0 gene expression') 
(58921.0, 'limited zika virus infection') 
(58917.0, 'protein mediates viral attachment') 
(58915.0, 'downstream viral gene expression') 
(58915.0, 'cell viral spread') 
(58914.0, 'viral protein ns2a responsible') 
(58914.0, 'nipah virus infection rather') 
(58914.0, 'human herpes virus 8') 
(58912.0, 'experimental bluetongue virus infection') 
(58910.0, 'study day 1 10') 
(58907.0, 'human viral infections') 
(58905.0, 'cell protein synthesis shutoff') 
(58901.0, 'two million na cells') 
(58901.0, '2 fibroblasts cells') 
(58898.0, 'two plains p 1') 
(58893.0, 'including hepatitis b virus') 
(58893.0, 'clara cell protein 16') 
(58891.0, 'viral system could') 
(58886.0, '2 mm mg 2') 
(58883.0, 'k 1 ϭ 2') 
(58883.0, 'detect viral associated rna') 
(58883.0, '0 cases per 1') 
(58882.0, '2 cells grown') 
(58879.0, 'specific type 2 responses') 
(58878.0, '1 gene expression') 
(58875.0, 'viral genomic rna samples') 
(58871.0, 'lane 2 versus 1') 
(58871.0, 'lane 1 versus 2') 
(58871.0, '2 x 2 l') 
(58868.0, 'infection causing clinical disease') 
(58868.0, 'group 1 could') 
(58868.0, '2 9 10 5') 
(58863.0, 'viral capsid protein') 
(58863.0, 'capsid viral protein') 
(58862.0, 'zika virus infection increases') 
(58861.0, 'viral gene expression profile') 
(58861.0, 'ci 2 · 1') 
(58861.0, 'ci 1 · 2') 
(58859.0, 'myeloid cells 2') 
(58852.0, 'corresponding virus infection') 
(58845.0, '1 cell deficiency') 
(58844.0, 'dengue virus 2') 
(58838.0, 'yield viral protein') 
(58836.0, 'different rna binding proteins') 
(58834.0, 'inhibits viral gene expression') 
(58827.0, 'severe viral infection') 
(58819.0, 'viral protein responsible') 
(58818.0, 'diseased cell expression data') 
(58818.0, '9837x 1 x 2') 
(58818.0, '2 1 x xrange') 
(58814.0, 'virus infection alone') 
(58814.0, 'human cancer cells provides') 
(58806.0, 'helper 2 cells') 
(58804.0, '1 cell extracts') 
(58800.0, 'primary human at2 cells') 
(58799.0, 'model rna virus') 
(58795.0, 'host cell could produce') 
(58795.0, 'different zika virus strains') 
(58792.0, 'target human cells') 
(58792.0, 'native viral protein') 
(58792.0, 'human target cells') 
(58790.0, 'cells exhibit increased expression') 
(58780.0, 'cell protein synthesis') 
(58777.0, 'two novel lineages 1') 
(58774.0, 'viral spike protein') 
(58774.0, 'recombinant n protein could') 
(58773.0, 'subsequent virus infection') 
(58771.0, 'aa viral protein') 
(58764.0, 'viral rna polymerase activity') 
(58759.0, 'facilitate viral gene expression') 
(58755.0, 'treated virus control group') 
(58754.0, 'human primary cells') 
(58749.0, 'based search system 1') 
(58747.0, 'zikv viral protein') 
(58745.0, '4 ], influenza virus') 
(58740.0, 'virus infection phase') 
(58735.0, 'one control cell line') 
(58733.0, 'common viral infection') 
(58733.0, '1 /− 2 product') 
(58730.0, 'comparing individual viral infection') 
(58729.0, 'one health ”; 2') 
(58722.0, 'novel virus ” could') 
(58719.0, 'murine hepatitis virus infection') 
(58709.0, 'severe respiratory virus infections') 
(58705.0, 'ten influenza virus proteins') 
(58702.0, 'infected type ii cells') 
(58701.0, 'encoded viral protein') 
(58693.0, 'rna virus sequences suggests') 
(58682.0, 'virus infection rather') 
(58680.0, '2 enters cells') 
(58674.0, 'viral genomic rna levels') 
(58671.0, 'virus infection prevented mortality') 
(58669.0, 'including respiratory syncytial virus') 
(58668.0, 'severe disease following infection') 
(58663.0, 'viral rna expression') 
(58662.0, 'high pure viral rna') 
(58652.0, "including 2 '- 5") 
(58643.0, 'utr )/ viral protein') 
(58643.0, 'relatively new virus associated') 
(58640.0, '≥ 1 cm 2') 
(58635.0, 'viral nucleocapsid protein fused') 
(58635.0, '5 respiratory syncytial virus') 
(58632.0, 'detect virus infection') 
(58628.0, 'cov membrane protein could') 
(58623.0, 'human liver cancer cells') 
(58621.0, 'rna virus samples') 
(58618.0, '2 microglial cells') 
(58617.0, 'virus infection resulted') 
(58615.0, 'common respiratory virus infections') 
(58613.0, 'c 2 h 5') 
(58606.0, 'viral rna replication level') 
(58599.0, 'lung viral infection') 
(58599.0, 'inhibit zika virus infection') 
(58598.0, 'cells employ two types') 
(58593.0, 'cells use different signals') 
(58589.0, '2 j ≤ 1') 
(58588.0, 'human b cell cdna') 
(58578.0, 'host cell surface proteins') 
(58578.0, 'golgi network protein 2') 
(58574.0, 'known viral rna sequences') 
(58567.0, 'viral protein accumulation') 
(58566.0, 'viral infection groups') 
(58566.0, '3 rubella virus strain') 
(58564.0, 'viral respiratory disease') 
(58564.0, 'viral protein np') 
(58564.0, 'viral np protein') 
(58561.0, 'one virus per established') 
(58560.0, '5 cells per experiment') 
(58560.0, '2 monolayer cells') 
(58558.0, 'ebola virus infection depends') 
(58550.0, 'positive viral antigen expression') 
(58550.0, 'different immune cell types') 
(58549.0, 'certain virus infection cascade6') 
(58549.0, '4 viral rna measured') 
(58545.0, 'host cell type used') 
(58533.0, 'cd45 2 cells') 
(58533.0, '2 family proteins expression') 
(58525.0, 'viral rna replication complex') 
(58523.0, 'achieve 2 h 2') 
(58520.0, '6 samples containing 1') 
(58520.0, '1 vs 2') 
(58502.0, 'infect human cells revealed') 
(58495.0, 'human intestinal epithelial cells') 
(58492.0, 'vaccinia virus expression system') 
(58476.0, '2 os cells') 
(58475.0, 'rna virus strains suggesting') 
(58473.0, 'cd40l 2 cells') 
(58471.0, 'severe influenza virus infections') 
(58467.0, 'two viral diseases') 
(58466.0, '2 transmissible gastroenteritis virus') 
(58462.0, 'relative viral infection ratio') 
(58459.0, 'viral protein inside') 
(58458.0, 'dengue virus infection late') 
(58456.0, 'rosetta 2 cells') 
(58455.0, '1 upon infection') 
(58454.0, 'hep 2 cells') 
(58452.0, 'early viral proteins include') 
(58445.0, 'damage human epithelial cells') 
(58442.0, 'beas2b cells pge 2') 
(58441.0, 'rna virus sequence') 
(58440.0, '2 ameliorates clinical disease') 
(58439.0, 'viral protein composition') 
(58439.0, 'cd69 2 cells') 
(58436.0, '1 volume 2') 
(58434.0, 'rna binding protein family') 
(58432.0, '2 virus stock') 
(58431.0, '3 %), 2 samples') 
(58428.0, 'given rna binding protein') 
(58420.0, 'virus rna levels') 
(58420.0, 'otherwise mild virus infection') 
(58413.0, 'viral protein movement') 
(58413.0, 'viral movement protein') 
(58411.0, 'human virus transmission') 
(58408.0, 'zika virus infection appears') 
(58407.0, 'cz cells 2') 
(58406.0, '2 trillion cells') 
(58400.0, 'huh7 cell protein bound') 
(58396.0, 'primary viral infection') 
(58395.0, 'human oral epithelial cells') 
(58392.0, 'virus positive patients') 
(58390.0, '2 mutantinfected cells') 
(58388.0, 'herpes simplex virus 2') 
(58385.0, 'block ebola virus infection') 
(58384.0, 'cells 2') 
(58384.0, '2 cells') 
(58378.0, '10 4 labeled cells') 
(58377.0, 'seasonal h1n1 virus infection') 
(58377.0, '2009 h1n1 virus infection') 
(58370.0, 'different host cell types') 
(58364.0, 'free protein expression system') 
(58362.0, '1 cell metastasis nodules') 
(58357.0, 'protein occasionally induces cell') 
(58354.0, 'tagged viral protein') 
(58354.0, '1 specific antibodies detected') 
(58348.0, 'structural protein 2') 
(58346.0, 'virus infection increases') 
(58345.0, '2 virus shares similarities') 
(58342.0, 'cells undergoing persistent infection') 
(58341.0, 'influenza virus related sequences') 
(58336.0, 'viral nonstructural protein nsp1') 
(58336.0, 'viral infections could lead') 
(58332.0, 'infected cells strongly increased') 
(58330.0, 'acute viral infection') 
(58316.0, '10 multiple viral infections') 
(58307.0, 'different viral infectious agents') 
(58305.0, 'viral nonstructural protein 3a') 
(58303.0, 'helper 1 cell') 
(58299.0, 'abundant viral protein') 
(58298.0, 'health care associated infection') 
(58297.0, 'viral protein 3d') 
(58291.0, 'enhance dengue virus infection') 
(58288.0, 'affect virus infection') 
(58281.0, 'viral protein hsv') 
(58281.0, 'hsv viral protein') 
(58279.0, 'different virus strains') 
(58278.0, '2 measles virus') 
(58270.0, 'viral attachment protein') 
(58267.0, 'viral protein measurement') 
(58265.0, '1 cell monolayers') 
(58258.0, 'two different rna genomes') 
(58256.0, 'prevent antibodyenhanced virus infection') 
(58254.0, 'systemic zika virus infection') 
(58252.0, 'prevent virus infection') 
(58242.0, 'us virus infection') 
(58242.0, 'infectious virus progeny could') 
(58237.0, 'positive singlestranded rna virus') 
(58223.0, 'two primary protein families') 
(58221.0, 'viral env protein') 
(58219.0, 'driven viral gene expression') 
(58215.0, 'viral gene remains associated') 
(58215.0, 'n protein expression due') 
(58215.0, 'infected control cells') 
(58215.0, 'extracted viral protein') 
(58215.0, 'control infected cells') 
(58212.0, 'one respiratory virus') 
(58202.0, 'aor 1 · 2') 
(58202.0, '2 cause natural infection') 
(58202.0, '0c43 virus infection therefore') 
(58199.0, 'hcv infection protein network') 
(58194.0, 'viral protein aids') 
(58191.0, '2 virus helicase') 
(58190.0, 'clade 2 virus') 
(58183.0, 'viral m2 protein') 
(58182.0, 'fhv ‐ 1 infection') 
(58179.0, '2 · 1') 
(58179.0, '1 · 2') 
(58175.0, '2 influenza b viruses') 
(58173.0, 'rabies virus infection suggested') 
(58171.0, 'vaccinia virus vp39 2') 
(58171.0, 'intracellular viral rna levels') 
(58170.0, 'several different cell cultures') 
(58170.0, 'sars viral infection') 
(58163.0, 'infection risk among patients') 
(58155.0, 'multiple influenza virus strains') 
(58155.0, '2 %), protein') 
(58153.0, 'crvs including influenza virus') 
(58149.0, 'including influenza virus') 
(58148.0, 'viral protein interacts') 
(58148.0, '1 infection remains elusive') 
(58146.0, 'based immune cells') 
(58145.0, 'two different crystallographic 3') 
(58142.0, 'vitro experimental viral infection') 
(58134.0, 'virus infection patterns') 
(58131.0, 'influenza virus rna') 
(58124.0, 'b cells including cd28') 
(58123.0, 'human airway epithelial cells') 
(58121.0, 'specific virus type') 
(58116.0, 'cov viral infection') 
(58115.0, '5 influenza virus') 
(58114.0, 'least one viral sequences') 
(58113.0, '1 vector infection') 
(58111.0, 'virus associated proteins') 
(58108.0, 'viral envelop protein glycosylation') 
(58107.0, '2 1 jilin university') 
(58103.0, 'infected cell rna mixed') 
(58101.0, 'various viral replication proteins') 
(58097.0, 'controlling viral gene expression') 
(58097.0, '2 family protein bax') 
(58094.0, 'several viral proteins increases') 
(58093.0, 'ehv ‐ 1 infection') 
(58092.0, 'infected cells produce type') 
(58090.0, 'fatal viral infection described') 
(58089.0, 'individual virus positive samples') 
(58084.0, 'vaccinia viral protein k3l') 
(58083.0, 'k virus infection') 
(58083.0, 'inhibit virus infection') 
(58082.0, 'cells involves two sets') 
(58081.0, 'viral lytic switch protein') 
(58074.0, 'viral protein bands') 
(58073.0, 'specific virus strains') 
(58073.0, 'human primary cell culture') 
(58068.0, 'virus genomic data available') 
(58064.0, 'viral nucleocapsid protein') 
(58064.0, 'previously described human protein') 
(58061.0, 'skin 1 2') 
(58060.0, 'treat chronic viral infection') 
(58054.0, '1 cell suspensions') 
(58051.0, 'viral accessory protein vpr') 
(58041.0, 'activated protein kinase 2') 
(58040.0, 'human host cell cr') 
(58034.0, 'including b cells') 
(58030.0, 'rna virus infections') 
(58026.0, 'infected cells showed lysis') 
(58025.0, 'infected new pro1190 cells') 
(58019.0, 'viral protein ns1') 
(58019.0, 'viral ns1 protein') 
(58016.0, '9 recurrent viral infection') 
(58014.0, 'study cell surface expression') 
(58014.0, 'contain virus infection') 
(58011.0, 'obtain viral sequence data') 
(58008.0, 'including 2 patients') 
(57997.0, 'human primate culture cells') 
(57987.0, 'oncogenic viral protein e6') 
(57981.0, 'hcv genotype 1 infection') 
(57980.0, 'virus infection stress stimuli') 
(57978.0, 'accessory viral protein') 
(57976.0, 'specific antibody plus protein') 
(57974.0, 'one influenza virus') 
(57972.0, 'perhaps viral gene expression') 
(57967.0, 'barr virus infection appears') 
(57964.0, 'viral infection must necessarily') 
(57964.0, 'least two cell types') 
(57960.0, 'infected blood cells caused') 
(57959.0, '1 per 5 million') 
(57956.0, 'measuring viral gene expression') 
(57950.0, 'nonstructural viral protein 2bc') 
(57949.0, 'specific b cell activation') 
(57945.0, 'including 2 ′, 5') 
(57940.0, 'three different protein') 
(57939.0, '2 indicates 1') 
(57938.0, '2 μl 1') 
(57938.0, '1 μl 2') 
(57935.0, '1 infection remains') 
(57933.0, 'viral coat protein') 
(57929.0, 'viral pa protein') 
(57925.0, 'viral protein refers') 
(57921.0, 'viral nonstructural protein') 
(57915.0, 'including rabies virus strains') 
(57910.0, '3 6 1') 
(57910.0, '3 1 6') 
(57908.0, 'different virus species') 
(57907.0, 'cov e protein could') 
(57905.0, 'modulate viral gene expression') 
(57901.0, 'negative replication control cells') 
(57901.0, 'h cells following treatment') 
(57892.0, 'influenza virus gene segments') 
(57883.0, 'vp1 viral protein') 
(57883.0, 'vascular cell adhesion protein') 
(57883.0, 'host clear infected cells') 
(57883.0, 'clear infected host cells') 
(57881.0, 'type 1 diabetes could') 
(57881.0, '1 cell') 
(57880.0, 'neutralizing virus infection') 
(57877.0, 'virus infection pattern') 
(57875.0, '10 cells per well') 
(57874.0, 'viral fiber protein') 
(57870.0, 'parainfluenza virus 2') 
(57868.0, 'specific marker protein analysis') 
(57867.0, 'human epithelial cells studied') 
(57866.0, 'cells 5 h later') 
(57859.0, 'specific host cell receptors') 
(57859.0, 'human viral strains') 
(57859.0, 'facilitate chimeric virus infection') 
(57854.0, 'viruses infect host cells') 
(57851.0, 'virus replication following treatment') 
(57841.0, 'whereas persistent viral infection') 
(57836.0, 'two clinical cases showed') 
(57835.0, 'viral protein 3a') 
(57831.0, 'viral ns protein 3abc') 
(57830.0, 'wuhan aphid virus 2') 
(57828.0, 'human epithelial type 2') 
(57822.0, 'day 2 post infection') 
(57818.0, 'viral hemagglutinin protein') 
(57817.0, 'viral protein incorporation') 
(57810.0, 'zika virus infection induces') 
(57809.0, 'cells express high levels') 
(57808.0, 'human host cell') 
(57803.0, 'necessarily viral gene expression') 
(57802.0, 'viral protein confer') 
(57796.0, 'viral protein cage ferritin') 
(57794.0, 'mayaro virus infection cycle') 
(57793.0, 'various influenza virus strains') 
(57789.0, 'infected hela cells showed') 
(57786.0, 'viral ns3 protein') 
(57786.0, 'ns3 viral protein') 
(57784.0, 'virus allow accelerated infection') 
(57775.0, 'normal human schwann cells') 
(57774.0, 'functional human nk cells') 
(57774.0, '10 4 ed cells') 
(57773.0, 'virus strains including hev') 
(57771.0, 'viral rna per well') 
(57769.0, 'virus infection cycle') 
(57768.0, 'suppress virus infection effectively') 
(57763.0, 'respiratory viral infections compared') 
(57761.0, 'viral protein l1') 
(57749.0, 'viral infection even') 
(57747.0, 'h7n9 avian virus infection') 
(57746.0, 'specific viral genes cannot') 
(57739.0, 'measles involves virus infection') 
(57738.0, 'viral viral') 
(57727.0, 'viral tat protein') 
(57727.0, 'viral protein tat') 
(57727.0, 'viral protein polymers') 
(57717.0, 'lake sinai virus 2') 
(57713.0, 'infectious virus could') 
(57707.0, 'viral gene expression module') 
(57704.0, 'nsp2 viral protein') 
(57704.0, '5 buffer containing 1') 
(57703.0, '2 cell culture') 
(57702.0, 'cultured human cells treated') 
(57701.0, 'cells expressing human ace2') 
(57700.0, 'one death per 1') 
(57694.0, 'viral rev protein') 
(57689.0, 'high virus detection rate') 
(57686.0, 'several different rna viruses') 
(57681.0, 'viral protein 2c') 
(57681.0, 'viral 2c protein') 
(57677.0, 'virus efficient infection') 
(57672.0, 'different host protein families') 
(57667.0, 'inhibit rna virus replication') 
(57661.0, 'authentic viral protein') 
(57654.0, 'viral infection process') 
(57648.0, 'virus infection leading') 
(57647.0, 'multifunctional viral protein') 
(57645.0, 'viral protein tax') 
(57645.0, 'persistent virus infection contributes') 
(57644.0, '2 mcherry virus') 
(57640.0, 'plant virus infection') 
(57634.0, 'patients without virus') 
(57632.0, '10 4 cells equivalent') 
(57630.0, 'viral orf2 protein') 
(57630.0, 'studies used viral culture') 
(57621.0, 'viral protein ns5a') 
(57617.0, 'herd 1 herd 2') 
(57616.0, 'however 1 -[ 2') 
(57614.0, 'h1n1 virus infection admitted') 
(57614.0, '2 ): 1') 
(57612.0, 'viral gn protein') 
(57600.0, 'trichomonas vaginalis virus 2') 
(57597.0, 'like cells could') 
(57594.0, 'viral haemagglutinin protein') 
(57594.0, 'beginning viral gene expression') 
(57591.0, 'viral dna could') 
(57585.0, 'one infectious virus particle') 
(57580.0, 'viral protein nef') 
(57577.0, 'viral protein abundances') 
(57577.0, 'cells produced increased levels') 
(57574.0, 'kshv infected cells showed') 
(57568.0, '10 4 vero cells') 
(57567.0, 'breda virus 2') 
(57566.0, 'viral protein immunostaining') 
(57564.0, 'immunoreactive viral protein') 
(57559.0, 'approximately 10 6 cells') 
(57554.0, 'virus }}= 2') 
(57552.0, 'human renal epithelial cells') 
(57548.0, 'infected vero cells increased') 
(57547.0, 'virus 2') 
(57547.0, '2 virus') 
(57546.0, 'viral ns2a protein') 
(57545.0, '4 cells infected') 
(57540.0, 'obtain 1 -[ 2') 
(57535.0, 'h 3 n 2') 
(57535.0, '3 n h 2') 
(57532.0, '1 comprises two active') 
(57531.0, '2 10 − 5') 
(57530.0, 'live virus infection') 
(57515.0, 'viral protein palmitoylation') 
(57515.0, 'infection control human resources') 
(57514.0, 'viral protein vp6') 
(57513.0, '2 •-), h 2') 
(57509.0, '2 h 2') 
(57500.0, 'viral envelop protein') 
(57499.0, 'high pathogenic influenza virus') 
(57495.0, 'viral protein vpg') 
(57494.0, '4 treated b cells') 
(57492.0, 'better control virus infections') 
(57490.0, 'including activated protein c') 
(57488.0, 'viral protein vif') 
(57487.0, 'viral protein p30') 
(57486.0, 'viral protein penton terry') 
(57481.0, 'cell protein degradation') 
(57480.0, 'viral protein 2bc') 
(57477.0, 'viral protein 3cd') 
(57477.0, 'active eukaryotic viral infection') 
(57475.0, 'treat human viral diseases') 
(57475.0, 'human complement receptor 1') 
(57475.0, 'domaincontaining viral protein') 
(57475.0, '3 respiratory viral') 
(57470.0, 'viral receptorbinding protein') 
(57468.0, 'hepatitis virus b gene') 
(57463.0, 'virus infection takes place') 
(57462.0, 'viral protein icp34') 
(57460.0, 'structural protein genes one') 
(57459.0, 'viral protein dp71l') 
(57458.0, 'viral protein glycosylations') 
(57457.0, 'pi329l viral protein') 
(57456.0, 'influenza virus m2 gene') 
(57455.0, 'mouse hepatitis virus 3') 
(57455.0, '3 mouse hepatitis virus') 
(57454.0, 'viral protein ns4p') 
(57454.0, 'viral ec27 protein') 
(57454.0, 'exapted viral protein') 
(57451.0, 'viral protein') 
(57451.0, 'influenza virus proteins') 
(57444.0, 'two receptor protein bands') 
(57437.0, 'infectious viral disease problem') 
(57436.0, 'viral genomic rna 6') 
(57431.0, '2 ð0þ ¼ 1') 
(57431.0, '1 ð0þ ¼ 2') 
(57430.0, 'directly inhibiting viral infection') 
(57427.0, 'productive target cell infection') 
(57426.0, 'two different sirnas specific') 
(57426.0, 'mediates dengue virus infection') 
(57419.0, 'b cells 0 h') 
(57417.0, 'viral infection must') 
(57412.0, '2 ¼ 1') 
(57411.0, 'virus infection efficiency') 
(57411.0, 'different blood cells') 
(57409.0, 'gc12 virus infection led') 
(57408.0, 'infected cell culture system') 
(57388.0, 'lower virus rna concentrations') 
(57384.0, 'following rna virus') 
(57384.0, '23 hendra virus infection') 
(57383.0, 'avian h9n2 virus infection') 
(57378.0, '1 infection alone') 
(57374.0, 'virus without clinical signs') 
(57370.0, 'two viral groups') 
(57370.0, '3 per 1') 
(57362.0, 'dysregulated viral gene expression') 
(57359.0, 'infected cells showed rounding') 
(57356.0, 'virus infection 22') 
(57348.0, '2 1 graduate school') 
(57344.0, 'virus infection leads') 
(57340.0, '1 ∶ 2 dilution') 
(57339.0, 'infected cells showed') 
(57320.0, 'control viral rna') 
(57317.0, 'restrict ebola virus infection') 
(57314.0, 'type 1 ifn expression') 
(57305.0, 'hepatitis c viral rna') 
(57302.0, 'liver patients without viral') 
(57301.0, 'miller 6 virus rna') 
(57300.0, 'ifitms influence virus infection') 
(57300.0, 'binding virus proteins') 
(57292.0, 'influenza virus ns1 gene') 
(57288.0, 'cells expressing antigen proteins') 
(57286.0, 'specific virus strain') 
(57283.0, 'cure ebola virus infection') 
(57282.0, 'viral gene expression evades') 
(57279.0, 'future respiratory virus studies') 
(57274.0, 'recent viral infection') 
(57272.0, 'several cell lines including') 
(57270.0, 'viral infection caused') 
(57266.0, 'upregulated upon viral infection') 
(57265.0, 'viral intestinal disease complex') 
(57265.0, 'two virus isolates') 
(57261.0, 'measured viral rna levels') 
(57256.0, 'viral gene expression') 
(57254.0, 'developed human cells') 
(57244.0, 'disease phase enhanced virus') 
(57243.0, 'viral rna per reaction') 
(57239.0, '3 protein levels') 
(57237.0, 'host cell could lead') 
(57226.0, 'three influenza virus types') 
(57209.0, 'latent viral infection occurs') 
(57207.0, 'several different viral') 
(57198.0, '1 activity based') 
(57196.0, 'infective rna virus species') 
(57196.0, 'completely abrogate virus infection') 
(57192.0, 'infection onto virus') 
(57186.0, 'viral replication could still') 
(57184.0, 'hpai h5n1 virus infection') 
(57184.0, 'h5n1 hpai virus infection') 
(57183.0, 'avian borna virus infection') 
(57181.0, '1 infection resulted') 
(57180.0, 'p 3 ck cells') 
(57180.0, 'acute uuk virus disease') 
(57178.0, 'hepatitis virus infection') 
(57172.0, 'novel human virus') 
(57161.0, 'cells could induce anti') 
(57155.0, 'avian virus infection') 
(57147.0, 'mammalian borna virus infection') 
(57138.0, 'specific cell types following') 
(57134.0, 'virus infection plays') 
(57134.0, 'following host cell binding') 
(57120.0, '1 l total rna') 
(57110.0, 'new viral rna') 
(57107.0, 'infected wild type cells') 
(57091.0, 'h1n1 pdm virus infection') 
(57090.0, 'specific related virus') 
(57083.0, 'two protein groups') 
(57081.0, 'viral infection rates') 
(57066.0, 'cell specific monoclonal antibody') 
(57065.0, 'human np epithelial cells') 
(57063.0, 'cell differentiation protein') 
(57061.0, 'new pandemic influenza virus') 
(57059.0, 'n protein could induce') 
(57054.0, 'h1n1 virus infection') 
(57048.0, '100 cells per group') 
(57043.0, 'influenza virus entry activity') 
(57031.0, 'b cell immune response') 
(57029.0, 'two cells shown') 
(57029.0, 'mixed virus infection') 
(57020.0, 'wt virus infection dysregulates') 
(57020.0, 'virus infection depends') 
(57020.0, 'ebola virus infection') 
(57018.0, '1 µl ddh 2') 
(57015.0, 'virus infection dynamics') 
(57014.0, 'wt virus infection') 
(57011.0, 'derived human immunodeficiency virus') 
(57009.0, 'cultured human epithelial cells') 
(57005.0, '2 µl 1') 
(57005.0, '1 rna sequence') 
(57004.0, 'various human cell lines') 
(56995.0, 'promote rna virus replication') 
(56993.0, 'determine virus infection') 
(56985.0, '2 1 department') 
(56984.0, '1 rna levels') 
(56982.0, 'h1n1 patients per 1') 
(56980.0, 'viral infection remains unclear') 
(56973.0, 'protein samples could') 
(56972.0, 'effective viral infection') 
(56960.0, 'induced transmembrane protein 3') 
(56956.0, '1 positive patients') 
(56955.0, 'target cell infection') 
(56951.0, 'human immunodeficiency virus therapy') 
(56948.0, 'patients without disease activity') 
(56943.0, 'viral infectious disease diagnostics') 
(56941.0, '1 %- 2') 
(56940.0, 'human b cell repertoire') 
(56935.0, 'virus infection titer') 
(56934.0, 'cells following immune activation') 
(56934.0, 'cell movement protein') 
(56933.0, 'infect human liver cells') 
(56933.0, 'host cell proteins involved') 
(56928.0, 'human virus pathogens') 
(56928.0, 'different infection control measures') 
(56927.0, 'viral diseases including hiv') 
(56925.0, '2 viral genomes') 
(56918.0, 'asymptomatic nipah virus infection') 
(56918.0, 'alpha herpes virus infection') 
(56916.0, 'h5n1 virus infection') 
(56916.0, 'dsrnas upon viral infection') 
(56913.0, 'cell wall protein') 
(56903.0, 'six virus infected mice') 
(56902.0, 'pneumonia among influenza virus') 
(56899.0, '46 virus specific assay') 
(56890.0, 'virus rna synthesis observed') 
(56890.0, 'protein antibodies could increase') 
(56889.0, 'whereas human u87 cells') 
(56889.0, '0 9 10 1') 
(56887.0, 'decrease virus infection') 
(56884.0, 'canine distemper virus infection') 
(56881.0, 'related b cell studies') 
(56876.0, '1 · 3 days') 
(56875.0, 'clinical respiratory viral testing') 
(56873.0, 'one virus type') 
(56873.0, '1 percent 2') 
(56867.0, 'selected viral proteins results') 
(56866.0, 'ornithine upon viral infection') 
(56858.0, 'cell attachment protein r1') 
(56858.0, '10 epithelial cells per') 
(56856.0, 'specific virus entry factor') 
(56847.0, 'block virus infection') 
(56841.0, 'ebola virus disease outbreak') 
(56838.0, 'produce human recombinant protein') 
(56837.0, 'omm upon viral infection') 
(56835.0, 'japanese encephalitis virus infection') 
(56833.0, 'upon viral infection') 
(56826.0, 'target cells including macrophages') 
(56826.0, 'influenza virus pb1 gene') 
(56826.0, 'even host cell expression') 
(56817.0, 'mock infection cells') 
(56817.0, 'cxcl1 protein levels could') 
(56815.0, '2 1 frameshift') 
(56808.0, 'persistent virus infection') 
(56807.0, 'human gastric epithelial cells') 
(56806.0, 'viral cell tropism') 
(56805.0, '2009 virus infection') 
(56802.0, 'limiting zika virus infection') 
(56799.0, 'binding protein 3') 
(56799.0, '3 binding protein') 
(56797.0, 'immune cells might provide') 
(56796.0, 'whereas influenza c virus') 
(56796.0, 'moderating dengue virus infection') 
(56796.0, '1 )/ 2') 
(56795.0, 'recent human virus') 
(56793.0, '1 3 25 mm') 
(56781.0, '1 proteins increased') 
(56779.0, 'dengue virus infection') 
(56772.0, '2 ae 1') 
(56771.0, 'virus infection susceptibility') 
(56770.0, 'human b cell neoplasms') 
(56766.0, 'prevent h1n1 viral infection') 
(56763.0, 'virus replication could') 
(56763.0, '10 4 hek293a cells') 
(56754.0, '10 4 cells') 
(56752.0, 'human gastric cancer cells') 
(56744.0, '7 cells increased significantly') 
(56743.0, 'inoculation 1 indicates infection') 
(56741.0, 'derived stem cells could') 
(56739.0, 'viral sequence data') 
(56734.0, 'infected cells increased') 
(56734.0, '1 showed high affinity') 
(56730.0, 'affects virus infection') 
(56727.0, "2 ', 1 ''-") 
(56723.0, 'reporter virus infection') 
(56722.0, 'two virus genomes') 
(56721.0, 'several viral envelope proteins') 
(56721.0, '1 infection co') 
(56718.0, '2 â 2 mm') 
(56717.0, 'control cells gradually increased') 
(56711.0, 'chronic viral infection') 
(56711.0, '3 ], ebola virus') 
(56710.0, 'secondary viral infection') 
(56704.0, 'club cell secretory protein') 
(56702.0, 'protein vi specific antibody') 
(56702.0, '2 infection causes activation') 
(56701.0, 'substantial virus infection') 
(56699.0, 'human 16 nk cells') 
(56698.0, '1 ca 2') 
(56694.0, 'including new compounds 2') 
(56691.0, 'initial viral infection') 
(56689.0, 'clara cell secretory protein') 
(56687.0, 'viral rna used') 
(56687.0, 'active viral infection') 
(56685.0, 'human b cell lymphomas') 
(56685.0, '1 +, 2 +,') 
(56674.0, 'cell proliferation 2 weeks') 
(56672.0, '1 group n strain') 
(56671.0, 'initiating chimeric virus infection') 
(56665.0, '1 infection ex vivo') 
(56659.0, '2 â 10 3') 
(56658.0, '2 protein bound adp') 
(56655.0, 'virus infection depending') 
(56648.0, '2 (− 1 )),') 
(56646.0, '2 2 x x') 
(56645.0, 'human cells treated') 
(56640.0, 'rotavirus virus infection') 
(56633.0, 'human nasopharyngeal epithelial cells') 
(56630.0, 'enteric virus infection') 
(56628.0, 'virus infection involve') 
(56624.0, '1 hcv infection') 
(56621.0, 'dowex 1 â 2') 
(56620.0, '21 domaincontaining protein 2') 
(56619.0, 'extracellular viral rna levels') 
(56615.0, 'cells making two') 
(56595.0, 'e75 lethal virus infection') 
(56592.0, 'secondary respiratory virus infections') 
(56586.0, 'sickle cell disease results') 
(56586.0, 'give two compounds 1') 
(56577.0, 'human b cell') 
(56569.0, 'ebola virus disease epidemic') 
(56566.0, 'viral infection occurs') 
(56565.0, '4 1 0 20') 
(56564.0, '10 viral proteins') 
(56559.0, '2 protein class') 
(56558.0, 'human epithelial carcinoma cells') 
(56556.0, 'virus might cause increased') 
(56556.0, 'infected cell rna') 
(56555.0, 'congenital zika virus infection') 
(56554.0, 'two different capsid proteins') 
(56554.0, 'target cells could') 
(56550.0, 'limit virus infection') 
(56546.0, 'human bronchial epithelial cells') 
(56545.0, 'ongoing virus infection') 
(56545.0, 'human cervical epithelial cells') 
(56545.0, '2 different vaccines strains') 
(56541.0, 'infected tissue culture cells') 
(56540.0, 'gastrointestinal virus infection') 
(56531.0, 'infected vertebrate host cells') 
(56527.0, 'endemic viral infection outbreaks') 
(56524.0, 'virus infection reduces') 
(56522.0, 'strand rna virus replication') 
(56521.0, 'differentiation associated protein 5') 
(56515.0, 'viral infection whereas') 
(56512.0, 'sustaining rabies virus infection') 
(56508.0, 'used two clinical strains') 
(56508.0, '5 1 0 µm') 
(56506.0, 'viral infectious disease belonged') 
(56505.0, 'used different cell') 
(56501.0, 'human breast cancer cells') 
(56498.0, 'g proteins per cell') 
(56493.0, 'two virus variants') 
(56486.0, 'associated virus directing expression') 
(56484.0, 'human transferrin receptor 1') 
(56476.0, 'cell gene expression datasets') 
(56474.0, 'protein specific antibody') 
(56468.0, 'blocking virus infection') 
(56463.0, 'bound protein 2') 
(56462.0, 'west nile virus infection') 
(56461.0, 'different duck primary cells') 
(56456.0, 'protein expression levels increase') 
(56456.0, 'influenza virus activity mainly') 
(56454.0, 'one virus species') 
(56452.0, 'protein sequence data') 
(56452.0, '2 cohorts 1') 
(56451.0, 'viral infection 15') 
(56449.0, '1 → 2') 
(56443.0, 'virus infection 42') 
(56435.0, 'human accelerated region 1') 
(56431.0, '2 os cell expressing') 
(56430.0, 'new viral proteins') 
(56430.0, 'mouth disease virus l') 
(56429.0, 'viral rna levels correlated') 
(56427.0, 'infected immune cells') 
(56424.0, 'receptor cells could') 
(56421.0, 'cell type specific differences') 
(56402.0, '2 knockdown cell lines') 
(56400.0, 'viral infection remains unanswered') 
(56400.0, 'n protein could represent') 
(56397.0, 'rabies virus infection') 
(56397.0, '1 case per 10') 
(56393.0, 'individual influenza virus strains') 
(56392.0, '1 ′, 2 ′)') 
(56388.0, 'type 1 diabetes patients') 
(56385.0, 'bovine herpesvirus 1 infection') 
(56383.0, 'multiple respiratory viral infections') 
(56382.0, 'human pancreatic cancer cells') 
(56382.0, 'contains human nk cells') 
(56377.0, 'compare virus infection') 
(56376.0, 'one virus due') 
(56372.0, '100μg cell lysate protein') 
(56371.0, 'iav virus infection') 
(56369.0, 'new viral respiratory pathogens') 
(56365.0, 'human diploid cells produced') 
(56363.0, 'diagnose specific viral infections') 
(56358.0, 'new human disease caused') 
(56354.0, 'homologous virus infection') 
(56353.0, 'cell protein lysates') 
(56351.0, 'human disease including morbidity') 
(56350.0, '2 ribonucleotide reductase 1') 
(56345.0, '2 endothelial cell media') 
(56344.0, 'zika virus infection poses') 
(56344.0, 'influenza viruses exit cells') 
(56339.0, 'viral pathogen infection') 
(56339.0, 'viral infection remains contentious') 
(56336.0, 'infectious viral cycle specific') 
(56333.0, '1 6 c p') 
(56332.0, 'binding protein could') 
(56331.0, '2 ∶ 1') 
(56331.0, '1 ∶ 2') 
(56328.0, '03 virus caused disease') 
(56324.0, '2 mm mgcl 2') 
(56324.0, '1 0 0 n') 
(56323.0, 'herpes simplex virus infection') 
(56319.0, 'infection cells') 
(56313.0, 'viral infection remains') 
(56311.0, '2 ′), 1') 
(56307.0, 'lower human infection rate') 
(56304.0, 'virus different f r') 
(56304.0, 'human corneal epithelial cells') 
(56296.0, 'viral infection state implies') 
(56294.0, 'cell division protein ftsz') 
(56293.0, 'outer capsid 2 protein') 
(56292.0, 'understand natural viral infection') 
(56291.0, 'conserved virus proteins e') 
(56283.0, '1 )( 2') 
(56282.0, 'virus infection presents') 
(56282.0, 'additional 1 3 subtypes') 
(56282.0, '2 ϭ 1') 
(56277.0, '1 ],[ 2') 
(56277.0, '1 /− 2 fs') 
(56276.0, '2 mm cacl 2') 
(56275.0, 'viral rna synthesis compared') 
(56274.0, 'two grid cells recorded') 
(56269.0, 'different viral infections') 
(56267.0, '3 cells expressed ace2') 
(56259.0, 'specific ige binding protein') 
(56255.0, 'virus population upon high') 
(56250.0, 'three viral proteins') 
(56247.0, 'infected host cells') 
(56244.0, '1 brain infection') 
(56243.0, 'human colonic epithelial cells') 
(56242.0, 'suppress virus infection') 
(56242.0, 'heterologous virus infection') 
(56236.0, '2 mm mncl 2') 
(56235.0, 'human melanoma cancer cells') 
(56232.0, 'virus activity previously reported') 
(56232.0, 'one case tumor cells') 
(56228.0, 'virus infection protected') 
(56226.0, '1 specific pcr reactions') 
(56224.0, '2 § 1') 
(56223.0, 'viral infection 30') 
(56223.0, '1 sm 2') 
(56219.0, 'large genome dna virus') 
(56218.0, '2 mm 2') 
(56217.0, 'infected health two events') 
(56215.0, 'emerging human viral pathogens') 
(56213.0, 'measles virus infection') 
(56212.0, 'viral infection ”') 
(56212.0, '2 ($ 1') 
(56212.0, '1 infection leading') 
(56211.0, 'viral infectious disease') 
(56211.0, 'two viral pathogens') 
(56211.0, 'infectious viral disease') 
(56207.0, 'n protein gene region') 
(56207.0, '1 /- 2') 
(56206.0, 'tag virus infection') 
(56206.0, '2 cell lines highlight') 
(56203.0, 'purified n protein could') 
(56202.0, 'cells showed positive staining') 
(56200.0, 'abolish latent virus infection') 
(56196.0, '1 )-( 2') 
(56193.0, 'viral infection mechanisms') 
(56189.0, 'viral infections including mhv') 
(56189.0, 'different host cell proteases') 
(56189.0, "2 '', 1 '''-") 
(56188.0, '0 ‐ positive cells') 
(56185.0, 'pox vaccinia virus infection') 
(56185.0, '1 }{ 2 }},') 
(56182.0, 'b cell epitopes could') 
(56181.0, '2 human cases') 
(56176.0, 'specific gene expression analysis') 
(56176.0, '2 3 10 à4') 
(56173.0, 'e c 1 6') 
(56172.0, 'miles 2 1 grad') 
(56170.0, 'major zoonotic viral disease') 
(56164.0, 'fio 2 1') 
(56157.0, '1 contained high levels') 
(56156.0, 'specific host protein') 
(56156.0, 'several common viral infections') 
(56154.0, 'different target cells') 
(56151.0, 'specific cell membrane sites') 
(56150.0, 'enveloped virus infection') 
(56148.0, '2 ’), 1') 
(56145.0, 'different tissue cells') 
(56143.0, '1 n hno 3') 
(56137.0, 'n 1 3') 
(56135.0, 'two adjacent cells') 
(56135.0, 'one cell per well') 
(56135.0, '2 1 dept') 
(56134.0, '1 -> 2') 
(56132.0, 'two total cell cycles') 
(56132.0, 'human ciliated epithelial cells') 
(56131.0, 'sendai virus infection regardless') 
(56131.0, 'human glomerular epithelial cells') 
(56129.0, 'cells expressing human hserca2a') 
(56126.0, 'human viral diseases') 
(56126.0, 'cells expressing human tmprss3') 
(56124.0, '2 +: 1') 
(56124.0, '1 }{{ 2') 
(56121.0, 'vesicular stomatitis virus infection') 
(56120.0, '1 -{[ 2') 
(56119.0, 'virus infection inactivation') 
(56119.0, 'reconstructm 1 andm 2') 
(56117.0, '1 ▪▪, 2') 
(56116.0, '2 viral load') 
(56114.0, '5441x 2 1') 
(56114.0, '2 +⋯+( 1') 
(56114.0, '1 health care staff') 
(56114.0, "1 --' 2") 
(56113.0, '1 therapy could produce') 
(56111.0, 'human cells expressing') 
(56111.0, '2 1') 
(56111.0, '1 2') 
(56108.0, 'cellular viral immune response') 
(56107.0, 'acute respiratory infection patients') 
(56104.0, '1 infection states') 
(56095.0, 'fish virus infection') 
(56094.0, 'vaccinia virus infection') 
(56092.0, 'blocks virus infection') 
(56091.0, 'positive sense viral rna') 
(56086.0, 'understanding rna virus replication') 
(56086.0, 'concurrent virus infection') 
(56085.0, 'human brain endothelial cells') 
(56085.0, '30 different virus isolates') 
(56078.0, 'herpes virus infection') 
(56074.0, 'h7n9 virus infection') 
(56070.0, 'human receptor protein ace2') 
(56063.0, 'specific viral infections') 
(56061.0, '2 cell line') 
(56059.0, '2 mg cell lysates') 
(56058.0, 'enhances virus infection') 
(56057.0, 'facilitates virus infection') 
(56051.0, 'human tonsillar epithelial cells') 
(56050.0, '3 ], sertoli cells') 
(56045.0, '1 rna genome indicated') 
(56039.0, 'two cell entry types') 
(56039.0, 'positive viral respiratory pcr') 
(56038.0, 'one virus strain') 
(56036.0, 'human tracheobronchial epithelial cells') 
(56026.0, 'two different patients') 
(56025.0, 'infected cells positive') 
(56023.0, 'positive respiratory viral test') 
(56022.0, 'cells could suppress hiv') 
(56021.0, 'various respiratory viral infections') 
(56020.0, 'protein quality control system') 
(56018.0, 'human hepatoma cancer cells') 
(56012.0, 'viral proteins might direct') 
(56012.0, 'viral dna ⁄ rna') 
(56012.0, 'overall viral infection') 
(56010.0, 'specific cells observed') 
(56010.0, 'human airway epithelium cells') 
(56009.0, 'initiate virus infection') 
(56007.0, 'viral proteins used') 
(56004.0, 'stranded rna virus like') 
(56001.0, 'infected cells per condition') 
(55999.0, 'affect host cell proteins') 
(55998.0, 'zika virus infection') 
(55993.0, '⁄ h3n2 virus infection') 
(55991.0, 'virus infection triggers') 
(55991.0, 'protein binding data') 
(55990.0, 'several viral proteins interact') 
(55984.0, 'first infected cells') 
(55979.0, '1 10 4 u') 
(55974.0, 'infection including segregating patients') 
(55972.0, 'cell protein') 
(55969.0, '1 infection occurring altogether') 
(55968.0, 'influenza infected cells') 
(55957.0, 'previous viral infection') 
(55957.0, '10 l containing 1') 
(55956.0, 'human adenocarcinomic epithelial cells') 
(55954.0, 'productive virus infection') 
(55954.0, '4 cells showed') 
(55952.0, 'human epithelial cells') 
(55948.0, 'target specific cells') 
(55948.0, 'specific target cells') 
(55946.0, 'recognition protein 2') 
(55944.0, 'virus infection 79') 
(55940.0, 'viral infection produced') 
(55939.0, 'potentially deadly viral infection') 
(55933.0, 'new influenza virus appeared') 
(55933.0, 'facilitating virus infection') 
(55932.0, '1 5 0 ltr') 
(55929.0, 'examine viral rna levels') 
(55926.0, 'dna profile analysis cells') 
(55921.0, 'viral infection state') 
(55921.0, 'including acute respiratory infection') 
(55918.0, 'cytopathic virus infection') 
(55910.0, 'several viral rna') 
(55910.0, 'host immune cells leading') 
(55909.0, 'cell mediated inflammatory disease') 
(55902.0, 'several viral gag proteins') 
(55899.0, 'infected cells without integration') 
(55897.0, 'human cancer cells') 
(55895.0, 'general control protein 4') 
(55891.0, 'protein kinase 2') 
(55883.0, 'oc43 virus infection') 
(55876.0, 'virus specific antibodies') 
(55875.0, 'h3n2 virus infection') 
(55874.0, '1 infection indicates') 
(55872.0, 'la crosse virus infection') 
(55872.0, 'induced protein 3') 
(55865.0, 'average ebola virus disease') 
(55864.0, 'two alternative protein receptors') 
(55858.0, 'virus infection stimulates') 
(55855.0, 'lymphocytic choriomeningitis virus infection') 
(55853.0, 'detect protein expression levels') 
(55850.0, 'viral infection 11') 
(55849.0, 'human respiratory tract infection') 
(55844.0, 'matrix protein 2') 
(55843.0, 'pulmonary viral infection') 
(55842.0, 'regulates virus rna replication') 
(55839.0, 'ibrs 2 cell lines') 
(55838.0, 'viral infection pathways') 
(55835.0, 'regulating rna virus replication') 
(55833.0, 'cell lines 2') 
(55833.0, '2 cell lines') 
(55830.0, 'approximately 2 cm 2') 
(55829.0, 'specific cell surface receptor') 
(55822.0, 'neutralize virus infection') 
(55819.0, 'zika virus disease outbreak') 
(55816.0, 'host innate immune cells') 
(55815.0, 'type 1 vwd patients') 
(55805.0, 'parainfluenza virus infection') 
(55802.0, 'prrs virus infection') 
(55799.0, '3 recombinant vaccinia virus') 
(55795.0, '4 2 7 4') 
(55795.0, '2 %), including influenza') 
(55794.0, 'surviving virus infection') 
(55794.0, 'corresponding viral infection') 
(55788.0, 'varicella zoster virus infection') 
(55787.0, 'h9n2 viral infection resulted') 
(55786.0, 'ebv infected b cells') 
(55784.0, 'positive stranded rna protein') 
(55783.0, 'numerous virus particles could') 
(55779.0, 'counter virus infection') 
(55778.0, 'new h1n1 influenza virus') 
(55778.0, 'least one 2 0') 
(55778.0, 'authentic sfts virus infection') 
